


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:48:59Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12405337" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12405337</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Med Microbiol Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Med Microbiol Immunol</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title>Medical Microbiology and Immunology</journal-title></journal-title-group><issn pub-type="ppub">0300-8584</issn><issn pub-type="epub">1432-1831</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12405337</article-id><article-id pub-id-type="pmcid-ver">PMC12405337.1</article-id><article-id pub-id-type="pmcaid">12405337</article-id><article-id pub-id-type="pmcaiid">12405337</article-id><article-id pub-id-type="pmid">40892293</article-id><article-id pub-id-type="doi">10.1007/s00430-025-00852-0</article-id><article-id pub-id-type="publisher-id">852</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Antibiotic-resistant <italic toggle="yes">Acinetobacter baumannii</italic> can be killed by a combination of bacteriophages and complement</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="C">Carmen</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Krzy&#380;ewska-Dudek</surname><given-names initials="E">Eva</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Patpatia</surname><given-names initials="S">Sheetal</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dulipati</surname><given-names initials="V">Vinaya</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mapelli</surname><given-names initials="SN">Sarah Natalia</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Meral</surname><given-names initials="A">Aycan</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kotimaa</surname><given-names initials="J">Juha</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kiljunen</surname><given-names initials="S">Saija</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Meri</surname><given-names initials="S">Seppo</given-names></name><address><email>seppo.meri@helsinki.fi</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff8">8</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/040af2s02</institution-id><institution-id institution-id-type="GRID">grid.7737.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 0410 2071</institution-id><institution>Translational Immunology Research Program, Department of Bacteriology and Immunology, Faculty of Medicine, </institution><institution>University of Helsinki, </institution></institution-wrap>Helsinki, Finland </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/020dggs04</institution-id><institution-id institution-id-type="GRID">grid.452490.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 4908 9368</institution-id><institution>Department of Biomedical Sciences, </institution><institution>Humanitas University, </institution></institution-wrap>Milan, Italy </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01dr6c206</institution-id><institution-id institution-id-type="GRID">grid.413454.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 1958 0162</institution-id><institution>Department of Immunology of Infectious Diseases, </institution><institution>Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, </institution></institution-wrap>Wroc&#322;aw, Poland </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/040af2s02</institution-id><institution-id institution-id-type="GRID">grid.7737.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 0410 2071</institution-id><institution>Human Microbiome Research Program, Department of Bacteriology and Immunology, Faculty of Medicine, </institution><institution>University of Helsinki, </institution></institution-wrap>Helsinki, Finland </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/056d84691</institution-id><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution>Division of Clinical Microbiology, Department of Laboratory Medicine, </institution><institution>Karolinska Institutet, </institution></institution-wrap>Stockholm, Sweden </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05d538656</institution-id><institution-id institution-id-type="GRID">grid.417728.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 1756 8807</institution-id><institution>Department of Research in Inflammation and Immunology, </institution><institution>IRCCS Humanitas Research Hospital, </institution></institution-wrap>Milan, Italy </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04b181w54</institution-id><institution-id institution-id-type="GRID">grid.6324.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0400 1852</institution-id><institution>Department BA6311 Immunotechnology, </institution><institution>VTT Technical Research Centre of Finland, </institution></institution-wrap>Espoo, Finland </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02e8hzf44</institution-id><institution-id institution-id-type="GRID">grid.15485.3d</institution-id><institution-id institution-id-type="ISNI">0000 0000 9950 5666</institution-id><institution> Diagnostic Center (HUSLAB), </institution><institution>Helsinki University Hospital, </institution></institution-wrap>Helsinki, Finland </aff></contrib-group><author-notes><fn fn-type="com"><p>Communicated by Isabelle Bekeredjian-Ding.</p></fn></author-notes><pub-date pub-type="epub"><day>2</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>214</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">496088</issue-id><elocation-id>40</elocation-id><history><date date-type="received"><day>13</day><month>3</month><year>2025</year></date><date date-type="accepted"><day>11</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="430_2025_Article_852.pdf"/><abstract id="Abs1"><p id="Par1">Infections caused by multidrug-resistant <italic toggle="yes">Acinetobacter baumannii</italic> are an emerging global health threat. Although phages have shown promising results in treating bacterial infections, the mechanisms of the combined effect of phages and innate immunity on clearing <italic toggle="yes">A. baumannii</italic> remain unclear. Here, we report a synergistic effect of the complement system and phages on clearing multidrug-resistant <italic toggle="yes">A. baumannii</italic>. We show that <italic toggle="yes">A. baumannii</italic> rapidly adapts and becomes resistant to phage or serum complement by modifying the expression of capsule and lipooligosaccharides, which can be regulated through reversible transposon mutagenesis in the K locus. Compared to the encapsulated phenotype, the non-encapsulated, phage-resistant <italic toggle="yes">A. baumannii</italic> showed a higher level of membrane attack complex deposition and were susceptible to killing by complement. In contrast, the encapsulated phenotype escaped the complement system by shedding the membrane attack complex to the environment. Thus, while the complement system targets the non-encapsulated phenotype, the phage infects and eliminates the encapsulated subpopulation. These results suggest means of combatting antibiotic-resistant <italic toggle="yes">A. baumannii</italic> by a simultaneous treatment with phages and complement, a combination which can be supplemented further with antibacterial antibodies.</p><sec><title>Graphical abstract</title><p id="Par2">
<graphic position="anchor" id="d33e282" orientation="portrait" xlink:href="430_2025_852_Figa_HTML.jpg"/>
</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1007/s00430-025-00852-0.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Complement system</kwd><kwd>Bacteriophage</kwd><kwd>Multidrug-resistant bacteria</kwd><kwd>Capsular polysaccharides</kwd><kwd>Transposon mutagenesis</kwd><kwd><italic toggle="yes">Acinetobacter baumannii</italic></kwd></kwd-group><funding-group><award-group><funding-source><institution>University of Helsinki (including Helsinki University Central Hospital)</institution></funding-source></award-group><open-access><p>Open Access funding provided by University of Helsinki (including Helsinki University Central Hospital).</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer-Verlag GmbH Germany, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par3"><italic toggle="yes">Acinetobacter baumannii</italic> is an opportunistic bacterium, that can cause nosocomial infections and has been ranked under the critical group in the WHO priority list for research and development of new antibiotics [<xref ref-type="bibr" rid="CR1">1</xref>]. This bacterium can cause pneumonia, meningitis, urinary tract infections, wound infections and sepsis [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Immunocompromised patients are particularly vulnerable, and infections caused by <italic toggle="yes">A. baumannii</italic> have become increasingly difficult to treat because of the development of multi-drug resistance [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par4">The complement system is part of the human innate immune system and plays a crucial role in defending against bacterial infections by triggering activation of one or more of the three complement pathways: the classical, lectin or alternative pathway. The classical pathway can be activated through the recognition of bacterial surfaces by IgG, IgM or through direct binding of C1q. IgG and IgM can further recruit C1q, which complexes with C1r and C1s to mediate the cleavage of C4 that generates C4a and C4b. When C2 binds to C4b it is cleaved by C1s to C2a and C2b, whereafter the complex of C4b2b constitutes the classical pathway C3 convertase [<xref ref-type="bibr" rid="CR6">6</xref>]. The lectin pathway can be triggered through the recognition molecules, mannan-binding lectin (MBL) or ficolins that recognise carbohydrates and acetylated moieties on bacterial surfaces, respectively [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Through the binding of the recognition molecules with the MBL-associated serine protease-2 (MASP-2), C4 and C2 are cleaved to form C4b2b [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Unlike the classical and the lectin pathways, the alternative pathway can be activated through the spontaneous hydrolysis of C3, forming C3(H<sub>2</sub>O) that can bind factor B and generate an initial C3 convertase C3(H<sub>2</sub>O)Bb. This will activate new C3 molecules to C3b that bind factor B. After cleavage of C3b bound B to Bb the actual alternative pathway C3 convertase C3bBb is generated. Eventually, all three pathways converge to activate C3 to the anaphylatoxin C3a and opsonin C3b. The C3-convertases will further activate C5 [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Subsequently, C5b recruits C6 to form a soluble C5b6 complex. Upon binding of C7 and C8 the C5b-7 and C5b-8 complexes may already bind and enter into membranes like the outer membranes of gram-negative bacteria. Finally, C9 associates with the C5b-8 complex, unfolds and becomes inserted into the membrane. Further binding of multiple C9 molecules leads to a polymeric C9 ring as part of the complement membrane attack complex (MAC) on the bacterial outer membrane, leading to increased permeability and target cell lysis [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR10">10</xref>].</p><p id="Par5">Among the many immune evasion mechanisms, some pathogenic bacteria have the ability to resist complement-mediated opsonophagocytosis or killing by hijacking C4BP or factor H [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>], which are soluble inhibitors of the C4b2b and C3bBb convertases, respectively [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Whether <italic toggle="yes">A. baumannii</italic> is able to escape the complement system by acquiring factor H remains elusive, as contradicting results have been reported [<xref ref-type="bibr" rid="CR15">15</xref>&#8211;<xref ref-type="bibr" rid="CR17">17</xref>]. However, it is known that <italic toggle="yes">A. baumannii</italic> can survive in normal human serum (NHS) and escape complement through the expression of outer membrane surface proteins CipA and Tuf, production of capsular polysaccharides, modulation of the lipopolysaccharide structures and protein O-glycosylation [<xref ref-type="bibr" rid="CR17">17</xref>&#8211;<xref ref-type="bibr" rid="CR24">24</xref>].</p><p id="Par6">As antibiotic-resistant <italic toggle="yes">A. baumannii</italic> have emerged and become increasingly prevalent, alternative therapies are urgently needed. Bacteriophages (phages), which are bacterial viruses, have shown their potential as an alternative therapeutic means to antibiotics [<xref ref-type="bibr" rid="CR25">25</xref>&#8211;<xref ref-type="bibr" rid="CR27">27</xref>]. Phages can kill their host bacterial cells by undergoing a lytic cycle, where the phages infect and propagate within the host by utilising its metabolic machinery. Eventually, the bacterial host cell is lysed upon the release of phage particles into the environment [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. However, as bacteria and phages are coevolving, phages can rapidly drive the selection of bacteria that are resistant to phages [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. This complicates the therapeutic application of phages to cure bacterial infections. Moreover, the fact that phagocytes and serum components, such as antibodies and C1q, can clear and inactivate phages, raises concerns about the efficacy of phages to infect and kill bacteria in the human body [<xref ref-type="bibr" rid="CR31">31</xref>&#8211;<xref ref-type="bibr" rid="CR34">34</xref>]. Although phages can be phagocytosed and neutralised in serum, they may induce an alternative bacterial killing pathway within macrophages [<xref ref-type="bibr" rid="CR35">35</xref>], or together with complement clear the bacteria in a synergistic manner [<xref ref-type="bibr" rid="CR36">36</xref>].</p><p id="Par7">In our previous work, we isolated <italic toggle="yes">A. baumannii</italic>-specific phages belonging to the family <italic toggle="yes">Autographviridae</italic> [<xref ref-type="bibr" rid="CR37">37</xref>]. In this work we demonstrate that <italic toggle="yes">A. baumannii</italic> can rapidly adapt and become resistant to phages or complement-mediated killing by undergoing morphological changes. Notably, even though <italic toggle="yes">A. baumannii</italic> may exist as heterogenous bacterial populations with distinct characteristics, our findings show that phages and the complement system have a synergistic effect on the killing of <italic toggle="yes">A. baumannii</italic>, a feature that could be exploited therapeutically.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Ethics statement</title><p id="Par8">The work was carried out under Helsinki University Hospital research permits for projects TYH2022315 and TYH202322. Written informed consents were obtained from each healthy blood donor. The work does not involve handling or storing patient samples such as tissues, blood, or cells, nor patient personal data. The bacterial strains used in the work have been obtained as pure cultures as anonymised and named based on their sequential storage number in the strain collection of the University of Helsinki research group.</p></sec><sec id="Sec4"><title>Serum collection</title><p id="Par9">Pooled normal human serum (NHS) was collected from 8 to 16 healthy donors. All donors provided a written consent. After allowing the drawn blood to clot, it was centrifuged at 1200 rcf for 10&#160;min. Equal volumes of sera from females and males were pooled, and complement activity was preserved by storage at&#8201;&#8722;&#8201;80&#160;&#176;C. Pooled heat-inactivated serum (HIS) was prepared by incubating NHS at 56&#160;&#176;C for at least 30&#160;min.</p></sec><sec id="Sec5"><title>Bacteria and bacteriophage strains</title><p id="Par10">The clinical <italic toggle="yes">A. baumannii</italic> 5542, 5707 and 5910 strains were isolated at the Helsinki University Central Hospital Diagnostic Center (HUSLAB). <italic toggle="yes">Acinetobacter</italic> viruses fBenAci001, fBenAci002 and fBenAci003, which infect <italic toggle="yes">A. baumannii</italic> 5542, 5707 and 5910 respectively, were isolated from Beninese wastewater [<xref ref-type="bibr" rid="CR37">37</xref>]. Production of phage lysates has been previously described [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. A phage-resistant <italic toggle="yes">A. baumannii</italic> 5910 strain (5910-R<sub>&#966;</sub>) was isolated from a single colony grown on a plaque through the double-layer agar plate method, as described earlier [<xref ref-type="bibr" rid="CR38">38</xref>]. 5910-R<sub>&#966;</sub> was incubated in Lysogeny broth (LB) containing 25% NHS overnight at 37&#160;&#176;C. Thereafter, the culture was passaged once more to LB with 25% NHS before plating the bacteria on an LB plate. A single colony of the survivors was isolated (5910-S<sub>&#966;</sub>). The serum- and phage-sensitivities of 5910-R<sub>&#966;</sub> and 5910-S<sub>&#966;</sub> were tested by determining the bacterial growth curves and using the double layer-agar method. All bacterial strains were grown in LB medium at 37&#160;&#176;C, with shaking unless stated otherwise. Bacteria and bacteriophages were stored in 30% glycerol and 8% DMSO, respectively, at&#8201;&#8722;&#8201;80&#160;&#176;C. Detailed information regarding the phenotype of <italic toggle="yes">A. baumannii</italic> 5910 strain and the BioSample accession numbers are summarised in Table <xref rid="MOESM1" ref-type="media">S1</xref>.</p></sec><sec id="Sec6"><title>Viability assay for <italic toggle="yes">A. baumannii</italic> and detection of heterogeneous bacterial populations</title><p id="Par11">Measurement of bacterial growth curves was performed as described previously with some modifications [<xref ref-type="bibr" rid="CR39">39</xref>]. Briefly, phage lysates were diluted in Tris<sup>++</sup> buffer [10&#160;mM Tris&#8211;HCl, 150&#160;mM NaCl, 2&#160;mM CaCl<sub>2</sub>, 0.5&#160;mM MgCl<sub>2</sub>, pH&#8201;=&#8201;7.3]. Phage fBenAci001 (1&#8201;&#215;&#8201;10<sup>6</sup> plaque-forming units (PFU)), fBenAci002 (1&#8201;&#215;&#8201;10<sup>4</sup> PFU) or fBenAci003 (1&#8201;&#215;&#8201;10<sup>6</sup> PFU) was added into wells of a honeycomb plate with or without HIS or NHS. Overnight bacterial cultures were refreshed in LB medium and incubated until the mid-exponential phase was reached (OD<sub>600</sub>&#8201;=&#8201;0.5 &#8211; 0.7). <italic toggle="yes">A. baumannii</italic> 5542 strain (1&#8201;&#215;&#8201;10<sup>6</sup>&#160;CFU), 5707 strain (1&#8201;&#215;&#8201;10<sup>6</sup>&#160;CFU) or 5910 strain (1&#8201;&#215;&#8201;10<sup>4</sup>&#160;CFU) were seeded into each well, and the final serum concentration was 25% after the addition of bacteria. Bacteria were grown in the honeycomb plate at 37&#160;&#176;C with shaking in a Bioscreen C analyzer (Growth Curves AB Ltd), and the bacterial growth was followed for 23&#160;h by monitoring the absorbance at 600&#160;nm every 20&#160;min. Similarly, for the detection of a heterogeneous bacterial population, the growth of three single colonies of the parental 5910 strain was monitored by measuring the absorbance at 600&#160;nm. Ten million bacteria from a refreshed culture were seeded into a well that either contained LB and Tris<sup>++</sup>, phage fBenAci003 (1&#8201;&#215;&#8201;10<sup>6</sup> PFU), HIS or NHS, with a final serum concentration of 25%. Measurement of the growth curves of preconditioned parental 5910 strain were performed in similar way after refreshing the overnight bacterial cultures in LB. To precondition the parental 5910 strain, a single colony was inoculated in LB supplemented with 25% HIS, 25% NHS or 10&#160;&#181;l of phage lysates (10<sup>7</sup>&#8211;10<sup>8</sup> PFU/ml) and incubated overnight at 37&#160;&#176;C.</p></sec><sec id="Sec7"><title>Rescue assay of serum-sensitive bacteria</title><p id="Par12">NHS or HIS were incubated with 100&#160;&#181;g/ml ravulizumab (Alexion), a monoclonal complement C5 blocking antibody, at room temperature for 35&#160;min. Ten million cells of refreshed 5910-R<sub>&#966;</sub> bacterial cultures in LB and Tris<sup>++</sup> were seeded into each well. The final serum concentration was 25% after the addition of bacteria. Bacteria were grown at 37&#160;&#176;C with continuous shaking and the growth was monitored every 20&#160;min for 24&#160;h with the BioScreen C analyzer at 600&#160;nm.</p></sec><sec id="Sec8"><title>Capsule staining</title><p id="Par13">Overnight bacterial cultures were pelleted and mixed with 10&#160;&#181;l of India ink (Lefranc &amp; Bourgeois) on a glass slide. The bacteria-ink solution was spread on the glass slide and air-dried before flooding the slides with 1% crystal violet for 2&#160;min. Excess crystal violet was removed by tilting and blotting the edges of the slides. A coverslip was mounted on top of the stained area while the slides were still wet. Stained bacteria were visualised under Olympus-BX51 fluorescent microscope with bright field at 100&#8201;&#215;&#8201;magnification. All images were acquired with the Olympus DP-70 camera attached to the microscope. The brightness and contrast of all images were adjusted by using Microsoft PowerPoint.</p></sec><sec id="Sec9"><title>Isolation and staining of capsular polysaccharides</title><p id="Par14">Bacterial capsular polysaccharides were isolated as described earlier [<xref ref-type="bibr" rid="CR40">40</xref>] with minor modifications. Briefly, bacteria were incubated overnight at 37&#160;&#176;C, 220&#160;rpm in LB medium that was either supplemented with 25% HIS, 25% NHS, or 10&#160;&#181;l of phage lysate (10<sup>7</sup>&#8211;10<sup>8</sup> PFU/ml). Overnight cultures were reinoculated in 20&#160;ml of LB without any supplements and incubated at 37&#160;&#176;C, 230&#160;rpm overnight. The pellet of overnight bacterial cultures was collected after centrifugation at 4690 rcf for 30&#160;min, followed by a wash in saline and centrifugation. Capsular polysaccharides were extracted by resuspending bacterial pellets in 50&#160;mM citrate buffer with 0.1% (v/w) n-tetradecyl-n,n-dimethyl-3-ammonio-1-propanesulfonate (zwitterreagent, Merck), pH 4.5, followed by incubation at 42&#160;&#176;C, 900&#160;rpm for 40&#160;min. The volume of added citrate buffer was adjusted according to the wet mass of the bacterial pellet to a concentration of 0.1&#160;g/ml. Samples were centrifuged at 16,000 rcf for 5&#160;min, and the supernatants were collected. Samples were separated on 4&#8211;20% Bis&#8211;Tris gels (Invitrogen) at 165&#160;V, 130&#160;mA for 35&#160;min with MES running buffer (Invitrogen). The gel was washed with Milli-Q water for 30&#160;min and stained with 0.1% (w/v) Alcian blue in 40% ethanol/ 60% 20&#160;mM sodium acetate with a pH of 4.75 for 1&#160;h at ambient temperature, followed by overnight incubation in 40% ethanol/60% of 20&#160;mM sodium acetate with a pH of 4.75 at ambient temperature to de-stain the gel. The gel was imaged under white light using a GelDoc XR imaging system (Bio-Rad).</p></sec><sec id="Sec10"><title>Lipooligosaccharide isolation and silver staining</title><p id="Par15">Bacteria were cultivated at 37&#160;&#176;C, 220&#160;rpm in LB or LB supplemented with 25% HIS, 25% NHS, or 10&#160;&#181;l of phage lysate (10<sup>7</sup>&#8211;10<sup>8</sup> PFU/ml). Overnight cultures were reinoculated in 50&#160;ml of LB without any supplements and further incubated at 37&#160;&#176;C, 220&#160;rpm overnight. The bacteria were harvested by centrifugation, and lipooligosaccharide (LOS) was extracted according to Galanos et al. [<xref ref-type="bibr" rid="CR41">41</xref>]. The extraction solution that was used contained aqueous phenol (90%), chloroform, and petroleum ether (PCP, b.p. 40&#8211;60&#160;&#176;C) mixed in a volume ratio of 2:5:8. Solid phenol was added in small portions to the mixture until a clear solution was obtained. Dry bacterial mass (100&#160;mg) was placed in a 5&#160;ml Eppendorf tube and 1&#160;ml of PCP solution was added. The mixture was stirred vigorously to a fine suspension at ambient temperature. Next, the cell suspension was centrifuged at 1500 rcf for 15&#160;min. Supernatant was collected and a second PCP extraction was performed. The pooled supernatants from two extractions were evaporated under a stream of N<sub>2</sub> at 40&#160;&#176;C. Small portions of distilled water were added until LOS was precipitated. Next, the mixture was centrifuged at 20,000 rcf for 20&#160;min, and the supernatant decanted. The precipitate was washed 3 times with 200&#160;&#181;l of 80% phenol, followed by 3 washes with 200&#160;&#181;l of acetone. After the last washing step, the sample was lyophilised. Dry samples were dissolved in distilled water by warming at 80&#160;&#176;C for 2&#160;min and brief sonication. Sample of 12.5&#160;&#181;g was analysed with SDS-PAGE by separation on 15% polyacrylamide gel. The separated LOS was visualised using silver staining according to Tsai and Frasch, and Fomsgaard et al. [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>], with minor modifications [<xref ref-type="bibr" rid="CR44">44</xref>]. The gel was imaged under white light using a GelDoc XR imaging system (Bio-Rad).</p></sec><sec id="Sec11"><title>Deposition of C5b-9 on bacterial surface and permeability staining</title><p id="Par16">Bacteria were inoculated in LB medium supplemented with 10&#160;&#181;l of phage lysate (10<sup>7</sup>&#8211;10<sup>8</sup> PFU/ml), 25% HIS or 25% NHS and incubated at 37&#160;&#176;C overnight with shaking. Overnight bacterial cultures were refreshed in LB medium and further cultivated until the mid-exponential phase was reached. For C5b-9 deposition and permeability staining, bacteria were harvested and washed with Tris<sup>++</sup>, whereafter 3&#8201;&#215;&#8201;10<sup>7</sup> bacterial cells were seeded into a 96-well plate. Bacteria were incubated with 25% HIS or NHS at 37&#160;&#176;C for 30&#160;min. Half of the bacteria-serum suspension was prepared for C5b-9 staining, and the other part was collected for permeability staining. For C5b-9 staining, the bacterial pellet was mixed with 5&#160;&#181;g/ml mouse-anti-human-C5b-9 neoepitope mAb (clone aE11, Hycult) and incubated for 45&#160;min at ambient temperature. The samples were further incubated with a secondary Alexa-488-labeled goat-anti-mouse-IgG antibody (Invitrogen) at ambient temperature for 45&#160;min. After washing, the bacteria were fixed with 1% paraformaldehyde (PFA) at ambient temperature for 15&#160;min. To assess cell permeability, 100&#160;&#181;l of sample was stained with 7-AAD (Invitrogen) according to the product description provided by the manufacturer. The bacteria were stained in a similar way for the detection of C5b-9 after treatment with 25% NHS for 3, 5, 10 and 30&#160;min, and the supernatant were collected for soluble C5b-9 detection. Samples were analysed using a CytoFLEX flow cytometer (Beckman Counter). To compare C5b-9 deposition between the different phenotypes from independent experiments, the geometric mean fluorescence intensity (gMFI) was normalised according to the level of C5b-9 deposited on 5910-R<sub>&#966;</sub> clone.</p><p id="Par17">To inhibit the classical and the lectin pathway, the bacteria were resuspended in Mg-EGTA buffer [10&#160;mM Tris&#8211;HCl, 13.33&#160;mM EGTA, 150&#160;mM NaCl, 7&#160;mM MgCl<sub>2</sub>, pH&#8201;=&#8201;7.3] and were seeded in a 96-well plate. The bacteria were incubated with 25% NHS in the Mg-EGTA buffer at 37&#160;&#176;C for 3, 5, 10 and 30&#160;min. Supernatant were collected for soluble C5b-9 detection, and the pellet were stained against C5b-9 and bound antibodies were detected as described above.</p></sec><sec id="Sec12"><title>Detection of soluble C5b-9</title><p id="Par18">Bacteria were cultivated in LB supplemented with 10&#160;&#181;l of phage lysate (10<sup>7</sup>&#8211;10<sup>8</sup> PFU/ml), 25% HIS or 25% NHS at 37&#160;&#176;C overnight with shaking. Overnight bacteria cultures were refresh in LB without supplements until the mid-exponential phase was reached. After washing the bacteria with Tris<sup>++</sup>, 3&#8201;&#215;&#8201;10<sup>7</sup> bacterial cells were seeded into each well of a 96-well plate. Bacteria were incubated in 25% NHS for 3, 5, 10 and 30&#160;min at 37&#160;&#176;C and the supernatant was collected after the reaction was terminated with EDTA (final concentration 10&#160;mM). Soluble C5b-9 in the supernatant was measured with MicroVue SC5b-9 Plus EIA (Quidel) by following the instructions provided by the manufacturer.</p></sec><sec id="Sec13"><title>Isolation of bacterial DNA, whole genome sequencing and genomic analysis</title><p id="Par19">Bacterial DNA was isolated with the JetFlex Genomic DNA Purification Kit (Thermo Fisher Scientific) following the protocol provided by the manufacturer. The quality of the isolated DNA was tested with a Qubit 4 machine (Invitrogen) and 1% agarose electrophoresis. Whole-genome sequencing of 5910, 5910-R<sub>&#966;</sub> and 5910-S<sub>&#966;</sub> were carried out by Novogene (UK) Co., Ltd by using Illumina Sequencing PE150 and PacBio Sequel II to obtain short and long reads, respectively. The A5-miseq pipeline was used to assemble the obtained Illumina sequences [<xref ref-type="bibr" rid="CR45">45</xref>]. Hybrid assembly was conducted using Unicycler v0.4.8 [<xref ref-type="bibr" rid="CR46">46</xref>]. The 5910-R<sub>&#966;</sub> and 5910-S<sub>&#966;</sub> clones were compared to the parental 5910 strain, and the reads were mapped to a reference genome with BWA-mem and variants were called with Freebayes. The comparisons were conducted on PATRIC by using the variant calling tool [<xref ref-type="bibr" rid="CR47">47</xref>]. Rapid annotation subsystems technology (RAST) was used for the annotation of the bacterial genome [<xref ref-type="bibr" rid="CR48">48</xref>&#8211;<xref ref-type="bibr" rid="CR50">50</xref>]. The O- and K-serotypes of <italic toggle="yes">A. baumannii</italic> were determined by Kaptive [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. Insertion sequence was identified by BLAST [<xref ref-type="bibr" rid="CR53">53</xref>] and ISfinder [<xref ref-type="bibr" rid="CR54">54</xref>]. Mutation within the K locus of the <italic toggle="yes">A. baumannii</italic> strains was identified after predicting the K-serotype of the bacterial strains using the Kaptive service. To verify the insertion sequence within glucose-6-phosphate isomerase (<italic toggle="yes">pgi</italic>), the local insertion region was amplified with Phusion High-Fidelity DNA Polymerase (Thermo Fisher Scientific) and the primer pairs gpi_IS_For (5&#8242;-TAGTTCAGCTGAATCCAAAG-3&#8242;) and gpi_IS_Rev (5&#8242;-TACTCCATCAAGGAACTCAG-3&#8242;). PCR products were isolated from 2% agarose gels with the GenElute Gel Extraction Kit (Merck). Sanger sequencing of the isolated PCR products was carried out by the Institute for Molecular Medicine Finland.</p></sec><sec id="Sec14"><title>RNA isolation and sequencing</title><p id="Par20">The parental <italic toggle="yes">A. baumannii</italic> 5910 strain was cultivated in LB or LB supplemented with phage lysate, 25% HIS or NHS, while 5910-R<sub>&#966;</sub> and 5910-S<sub>&#966;</sub> were inoculated in LB only. Bacteria were incubated at 37&#160;&#176;C, 220&#160;rpm overnight. On the next day, the overnight cultures were refreshed in LB medium without any supplements and harvested after the bacteria reached the exponential phase. RNAprotect Bacteria Reagent (QIAGEN) was used to stabilise the bacterial RNA, before the bacterial pellets were stored at&#8201;&#8722;&#8201;80&#160;&#176;C. The bacteria were lysed with TRIzol Reagent (Invitrogen), and the RNA was isolated with the RNeasy kit according to the protocol provided by the manufacturer (QIAGEN). The quality control and the Illumina Sequencing PE150 of the samples were carried out by Novogene (UK) Co., Ltd. To analyse the expression level of genes in 5910 clones, the sequencing reads were aligned against <italic toggle="yes">A. baumannii</italic> H32 (NCBI RefSeq assembly GCF_030009215.1) using the Chipster platform with the BowtieTie2 pipeline [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. Differential gene expression was analysed with DESeq2 package (Bioconductor) in Rstudio [<xref ref-type="bibr" rid="CR57">57</xref>]. Genes were prefiltered, removing those with a raw coverage less than 10 reads. Subsequently, the genes were normalised with variance stabilising transformation (VST). Wald test was computed with the same library. Genes with a log twofold change larger than 1 or less than&#8201;&#8722;&#8201;1, and with a padj-value less than 0.05 were considered to be expressed with a significant difference.</p></sec><sec id="Sec15"><title>Prediction of depolymerase activity</title><p id="Par21">The DNA sequences of the phage tail spike proteins were uploaded to PhageDPO Phage Depolymerase Finder (Galaxy server of University of Minho, Version 0.1.0) to predict the depolymerase activity [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>].</p></sec><sec id="Sec16"><title>Quantification and statistical analysis</title><p id="Par22">Deposition of C5b-9 on the bacterial surface and changes in permeability were analysed with FlowJo. Computation of area under the curves and statistical analyses were performed with GraphPad Prism 9. Mann&#8211;Whitney and One-Way ANOVA with Kruskal&#8211;Wallis tests were used for the analyses.</p></sec></sec><sec id="Sec17"><title>Results</title><sec id="Sec18"><title>Synergistic effect of complement and bacteriophages on killing of <italic toggle="yes">A. baumannii</italic></title><p id="Par23">According to in vivo studies, certain phages may become neutralised by C1q of the complement system or by preexisting antibodies in sera from mammals [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. Hence, we initially assumed that the complement system might also neutralise the <italic toggle="yes">Acinetobacter</italic> phages, which would reduce the efficacy of the phages to infect their respective bacterial hosts. To examine whether the complement system inhibits phages from infecting and killing <italic toggle="yes">A. baumannii</italic> 5910, the bacterial growth was monitored when treated with the phage fBenAci003, heat-inactivated serum (HIS), normal human serum (NHS) or a combination of the phage and serum (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>). Upon treatment with the phage, the bacterial growth was delayed up to 5&#160;h. Thereafter, the bacteria started to grow exponentially (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>A), indicating the development of resistance to the phage. Although the bacterial growth was more retarded upon treatment with 25% HIS or NHS compared to the phage only (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>B and C), the bacteria showed resistance to complement-mediated killing. Strikingly, when <italic toggle="yes">A. baumannii</italic> was incubated with NHS in combination with the phage, the bacterial growth was completely abolished (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>C). Importantly, we also observed the same phenomenon for other <italic toggle="yes">A. baumannii</italic> strains (Fig. <xref rid="MOESM1" ref-type="media">S1</xref>). Together, this suggests a synergism between the complement system and phages in killing the tested <italic toggle="yes">A. baumannii</italic> strains.</p><p id="Par24">
<fig id="Fig1" position="float" orientation="portrait"><label>Fig.&#160;1</label><caption><p>Synergistic effects of complement and bacteriophage fBenAci003 on killing <italic toggle="yes">A. baumannii</italic> 5910. Ten thousand cells of <italic toggle="yes">A. baumannii</italic> parental 5910 strain were seeded into each well and treated with fBenAci003 phage and or 25% serum. The bacterial growth was monitored by measuring absorbance at 600&#160;nm. <bold>A</bold> Bacteria infected with the phage with a multiplicity of infection of 10 (MOI&#8201;=&#8201;10). <bold>B</bold> Bacteria grown in 25% heat-inactivated serum (HIS) alone or in combination with the phage (MOI&#8201;=&#8201;10). <bold>C</bold> Bacteria grown in 25% normal human serum (NHS) alone or in combination with the phage (MOI&#8201;=&#8201;10). Plots of two independent biological experiments with technical triplicates. Means&#8201;&#177;&#8201;SEM of six measurements are shown (n&#8201;=&#8201;6). The data were normalised to absorbance at 600&#160;nm at t&#8201;=&#8201;0&#160;h, and the area under the curve (AUC) was calculated. To compare the AUC of two conditions, Mann&#8211;Whitney test was used (<bold>A</bold>). The AUC was analysed with ANOVA and Kruskal&#8211;Wallis test for multiple comparisons of <italic toggle="yes">p</italic>-values (<bold>B</bold>, <bold>C</bold>). *<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0442, **<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0022, ***<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0002, ****<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001</p></caption><graphic id="d33e819" position="float" orientation="portrait" xlink:href="430_2025_852_Fig1_HTML.jpg"/></fig>
</p></sec><sec id="Sec19"><title>Phage-resistant bacteria are sensitive to complement</title><p id="Par25">After observing the emergence of resistance to phage-mediated killing of <italic toggle="yes">A. baumannii</italic> 5910, a single phage-resistant clone (5910-R<sub>&#966;</sub>) was isolated. After verification of the phage resistance of 5910-R<sub>&#966;</sub> (Fig. <xref rid="MOESM1" ref-type="media">S2</xref>), these bacteria were treated with serum and the viability was monitored (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>). Remarkably, upon incubation with NHS, the bacterial growth of 5910-R<sub>&#966;</sub> was delayed up to 13&#160;h of incubation. This was in contrast to parental 5910 strain, which showed no growth reduction (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>B). Despite the 5910-R<sub>&#966;</sub> clone showing less fitness in 25% NHS at early time points, these bacteria were able to survive in the serum environment as they began growing after 13&#160;h of incubation. Interestingly, when the 5910-R<sub>&#966;</sub> clone was incubated in NHS with a concentration below 4%, the growth of these bacteria was no longer hampered (Fig. <xref rid="MOESM1" ref-type="media">S3</xref>). Indicating that the alternative pathway might be involved in the killing of the bacteria, since the alternative pathway usually is no longer active at serum concentrations below 5%.</p><p id="Par26">
<fig id="Fig2" position="float" orientation="portrait"><label>Fig.&#160;2</label><caption><p>The phage-resistant 5910-R<sub>&#966;</sub> clone is sensitive to killing by normal human serum. <bold>A</bold>, <bold>B</bold> Growth curves of the parental 5910 strain and the phage-resistant 5910-R<sub>&#966;</sub> clone in serum. One million bacterial cells were seeded in each well with 25% HIS (<bold>A</bold>) or 25% NHS (<bold>B</bold>). Plots of two independent biological experiments with technical triplicates. Means&#8201;&#177;&#8201;SEM of six measurements are shown (n&#8201;=&#8201;6). <bold>C</bold>&#8211;<bold>E</bold> Growth curves of phage-resistant <italic toggle="yes">A. baumannii</italic> 5910-R<sub>&#966;</sub> in medium (<bold>C</bold>), 25% HIS (<bold>D</bold>), 25% NHS (<bold>E</bold>) and with or without the C5 inhibitor, ravulizumab (100&#160;&#956;g/ml). Ten million cells were seeded in each well. Depicted are plots of three independent biological experiments with technical triplicates. Means&#8201;&#177;&#8201;SEM of nine measurements are shown (n&#8201;=&#8201;9). The data were normalised to absorbance at 600&#160;nm at t&#8201;=&#8201;0&#160;h, and the AUC was calculated. To compare the AUC of conditions, Mann&#8211;Whitney test was used (A-E). **<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0022, ****<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001</p></caption><graphic id="d33e904" position="float" orientation="portrait" xlink:href="430_2025_852_Fig2_HTML.jpg"/></fig>
</p><p id="Par27">To confirm that the 5910-R<sub>&#966;</sub> clone was killed by the complement system, the monoclonal antibody ravulizumab was used to inhibit C5 to prevent the formation of membrane attack complex, C5b-9 [<xref ref-type="bibr" rid="CR61">61</xref>]. Treatment of the 5910-R<sub>&#966;</sub> clone with ravulizumab alone did not facilitate bacterial growth, as the growth kinetics were identical between the bacteria treated with medium or HIS only and when supplemented with ravulizumab (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>C and D). In contrast to the NHS-only treated 5910-R<sub>&#966;</sub> clone, where the bacteria were rapidly lysed within the first 10&#160;h, NHS supplemented with ravulizumab no longer killed the bacteria, as the monitored growth curve was similar to that of HIS-treated bacteria (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>E).</p></sec><sec id="Sec20"><title>Increased permeability and MAC deposition on phage-resistant <italic toggle="yes">A. baumannii</italic></title><p id="Par28">Upon prolonged incubation of the 5910-R<sub>&#966;</sub> clone in NHS, a survivor clone (5910-S<sub>&#966;</sub>) was isolated (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>A). Interestingly, the 5910-S<sub>&#966;</sub> clone showed similar features to the parental 5910 strain, as both strains were susceptible to the phage fBenAci003 and serum-resistant (Figs. <xref rid="MOESM1" ref-type="media">S2</xref> and <xref rid="MOESM1" ref-type="media">S4</xref>). Following the above observations, we sought to investigate, whether the serum-sensitivity of the bacteria correlated with the level of permeability and the deposition of C5b-9 on the bacterial surface with flow cytometry. Indeed, the 5910-R<sub>&#966;</sub> clone showed a 50% increase in C5b-9 deposition relative to 5910-S<sub>&#966;</sub>, while the parental 5910 strain showed a large variation (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>B). Heterogeneity in sensitivity to MAC attack among the parental 5910 strain indicated coexistence of different subpopulations, probably due to phase variation [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. Accordingly, we observed variations in phage- and serum sensitivity among the parental 5910 colonies (Figs. <xref rid="Fig3" ref-type="fig">3</xref>C, <xref rid="MOESM1" ref-type="media">S5</xref>). Importantly, when the bacteria (colony 3) were resistant to the phage fBenAci003, they were sensitive to complement-mediated killing, and vice versa (colonies 1 and 2).</p><p id="Par29">
<fig id="Fig3" position="float" orientation="portrait"><label>Fig.&#160;3</label><caption><p>Phase variation in <italic toggle="yes">A. baumannii</italic> 5910 affects C5b-9 deposition on the bacterial surface. <bold>A</bold> Schematic illustration of bacterial population selection. To isolate the phage-resistant phenotype 5910-R<sub>&#966;</sub>, the parental 5910 strain was treated with the phage fBenAci003 through double-agar layer method, and a single colony grown on a clear plaque was isolated. 5910-R<sub>&#966;</sub> was then treated with 25% NHS overnight, the survivors were plated and 5910-S<sub>&#966;</sub> was isolated. To enrich a certain bacterial population, parental 5910 was preconditioned in liquid medium supplemented with 25% HIS (5910 HIS&#8217;), 25% NHS (5910 NHS&#8217;) or with the phage fBenAci003 (5910 Phage&#8217;) overnight. <bold>B</bold> C5b-9 deposition on the <italic toggle="yes">A. baumannii</italic> 5910 phenotypes. Parental 5910 strain, 5910-R<sub>&#966;</sub>, and 5910-S<sub>&#966;</sub> were treated with 25% NHS for 30&#160;min before staining with antibodies, and detection of C5b-9 deposition was measured with flow cytometry. To compare C5b-9 deposition between the different phenotypes from independent experiments, the gMFI was normalised according to the level of C5b-9 deposition on 5910-R<sub>&#966;</sub> in each experiment. Six independent biological replicates with technical duplicates. Mean&#8201;&#177;&#8201;SEM of 12 measurements are shown (n&#8201;=&#8201;12). <bold>C</bold> Phage- and serum sensitivity of different colonies of the parental <italic toggle="yes">A. baumannii</italic> 5910 strain. Ten million bacterial cells were seeded into each well and were either infected with the phage fBenAci003 (MOI&#8201;=&#8201;0.1) or treated with 25% serum. The bacterial growth of three individual colonies of the parental 5910 strain was monitored by measuring the absorbance at 600&#160;nm. The data were normalised to absorbance at 600&#160;nm at t&#8201;=&#8201;0&#160;h. Means&#8201;&#177;&#8201;SD of technical duplicates are shown (n&#8201;=&#8201;2). <bold>D</bold>, <bold>E</bold> C5b-9 deposition and outer membrane permeability on preconditioned <italic toggle="yes">A. baumannii</italic> 5910 phenotypes. The parental 5910 strain was preconditioned overnight with serum or with the phage fBenAci003 as depicted in Fig.&#160;3A. All bacterial cultures were refreshed in LB without any supplements before treatment with 25% NHS for 30&#160;min. The bacteria were stained with antibodies to detect C5b-9 deposition (<bold>D</bold>) and 7-AAD for permeability (<bold>E</bold>). 7-AAD is a membrane-impermeant DNA dye, which only stains cells with compromised membrane integrity. The signals were measured with flow cytometry. <bold>F</bold> Soluble C5b-9 formation on <italic toggle="yes">A. baumannii</italic> 5910 phenotypes. Bacteria were treated with 25% NHS for 30&#160;min, and the amount of soluble C5b-9 formed in the supernatant was detected with ELISA. The level of complement autoactivation in serum at 37&#160;&#176;C over time is represented as NHS only condition without any bacteria. Data points represent three independent biological experiments with technical duplicates (<bold>D</bold>&#8211;<bold>F</bold>). Means&#8201;&#177;&#8201;SEM of six measurements are shown (n&#8201;=&#8201;6). <bold>B</bold>, <bold>D</bold>&#8211;<bold>F</bold> Statistical analysis was performed with ANOVA and Kruskal&#8211;Wallis test for multiple comparisons of <italic toggle="yes">p</italic>-values. *<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0350, **<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0066, ***<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0007</p></caption><graphic id="d33e1061" position="float" orientation="portrait" xlink:href="430_2025_852_Fig3_HTML.jpg"/></fig>
</p><p id="Par30">To enrich a certain subpopulation within a colony of the parental 5910 strain, the bacteria were preconditioned with 25% serum or with the phage fBenAci003 overnight (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>A). The enriched subpopulation was controlled by monitoring the bacterial growth in the presence of the phage fBenAci003 or with serum (Figs. <xref rid="MOESM1" ref-type="media">S6</xref>&#8211;<xref rid="MOESM1" ref-type="media">S7</xref>). Strikingly, all of the NHS preconditioned bacteria were sensitive to phage-mediated killing, while the bacteria that were preconditioned with phage were resistant (Figs. <xref rid="MOESM1" ref-type="media">S6</xref>A, <xref rid="MOESM1" ref-type="media">S7</xref>C and <xref rid="MOESM1" ref-type="media">S7</xref>D). In contrast, LB or HIS preconditioned bacteria showed variation in phage- and serum-sensitivity between colonies (Fig. <xref rid="MOESM1" ref-type="media">S6</xref>A, B). Thus, preconditioning of <italic toggle="yes">A. baumannii</italic> 5910 with NHS or phage could efficiently enrich a desired subpopulation. Nevertheless, after preconditioning with NHS (5910 NHS&#8217;), the bacteria showed a sixfold decrease in C5b-9 deposition compared to 5910-R<sub>&#966;</sub> (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>D). Moreover, the membrane permeability of 5910-R<sub>&#966;</sub> positively correlated with the level of C5b-9 deposition, where 5910-R<sub>&#966;</sub> showed more than 70-fold increase compared to 5910 in LB (5910 LB), preconditioned with HIS (5910 HIS&#8217;), 5910 NHS&#8217; or 5910-S<sub>&#966;</sub> (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>E). Notably, soluble C5b-9 formation negatively correlated with the deposition of C5b-9 on the bacterial surface (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>F). This indicated that all <italic toggle="yes">A. baumannii</italic> phenotypes activated the complement system, but the C5b-9 complex was efficiently inserted only on the phage-resistant cells, which became thereby rapidly killed.</p><p id="Par31">To gain a better understanding on the kinetics of C5b-9 formation by the different phenotypes, we chose to focus on the 5910 NHS&#8217;, 5910-R<sub>&#966;</sub> and 5910-S<sub>&#966;</sub> phenotypes for the measurement of the MAC deposition and formation of soluble C5b-9 over time (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>). When all the three complement pathways were active, C5b-9 was rapidly formed on the 5910-R<sub>&#966;</sub> surface, and the deposition was significantly stronger compared to 5910 NHS&#8217; and 5910-S<sub>&#966;</sub> at 10&#160;min of incubation with 25% NHS (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>A). In accordance with Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>F, 5910 NHS&#8217; and 5910-S<sub>&#966;</sub> generated higher levels of soluble C5b-9 relative to 5910-R<sub>&#966;</sub> over time (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>B). Probably, the detected level of soluble C5b-9 by 5910-R<sub>&#966;</sub> came from autoactivation of the serum as indicated in the NHS only condition without any bacteria. Next, we inhibited activation of the classical and lectin pathways with Mg-EGTA to investigate whether the alternative pathway became activated by the different phenotypes. Interestingly, C5b-9 deposition on 5910-R<sub>&#966;</sub> was retarded under alternative pathway activation conditions (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>C), whereas C5b-9 was rapidly deposited on the 5910 NHS&#8217; at 10&#160;min of incubation, and on the 5910-S<sub>&#966;</sub> clone at a later time point. Finally, formation of soluble C5b-9 followed a similar trend as the deposition of C5b-9 on the bacteria, when only the alternative pathway was activated (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>D). Together, these results suggest that different complement pathways are activated depending on the bacterial phenotype. In the case of 5910-R<sub>&#966;</sub>, the classical and lectin pathways seem to play a crucial role in a rapid activation of the terminal pathway and killing of the bacteria, whereas the alternative pathway is predominantly activated by 5910 NHS&#8217; and 5910-S<sub>&#966;</sub>. However, C5b-9 is rapidly shed from the 5910 NHS&#8217; and 5910-S<sub>&#966;</sub> clones to the environment.</p><p id="Par32">
<fig id="Fig4" position="float" orientation="portrait"><label>Fig.&#160;4</label><caption><p>Kinetics of C5b-9 deposition on <italic toggle="yes">A. baumannii</italic> 5910 phenotypes. The parental 5910 strain preconditioned with 25% NHS (5910 NHS&#8217;), 5910-R<sub>&#966;</sub> and 5910-S<sub>&#966;</sub> were incubated in LB overnight. All bacterial cultures were refreshed in LB without any supplements before treatment with 25% NHS for 30&#160;min. <bold>A</bold>, <bold>B</bold> The classical, lectin and the alternative pathways were activated when Tris.<sup>++</sup> buffer was used. <bold>C</bold>, <bold>D</bold> The classical and lectin pathways were inhibited with Mg-EGTA. Activation of complement was measured at different time points by detecting C5b-9 deposition on the bacterial surfaces with flow cytometry (A,C) and the formation of soluble C5b-9 was determined by ELISA (B,D). The level of complement autoactivation in serum at 37&#160;&#176;C over time is represented as NHS only condition without any bacteria. Data points represent three independent biological replicates with technical duplicates (<bold>A</bold>&#8211;<bold>D</bold>). Means&#8201;&#177;&#8201;SEM of six measurements are shown (n&#8201;=&#8201;6)</p></caption><graphic id="d33e1195" position="float" orientation="portrait" xlink:href="430_2025_852_Fig4_HTML.jpg"/></fig>
</p></sec><sec id="Sec21"><title><italic toggle="yes">Acinetobacter baumannii</italic> undergoes morphological changes upon phage treatment</title><p id="Par33">Next, we studied morphological changes of the bacteria after treatment with the phage fBenAci003 and serum. By staining the bacterial capsule and isolating capsular polysaccharides from the bacteria, the 5910 LB, 5910 HIS&#8217;, 5910 NHS&#8217; and the 5910-S<sub>&#966;</sub> phenotypes were found to produce an extensive amount of capsular polysaccharide, as these bacteria were positively stained with a halo around the cell. In contrast, the parental strain preconditioned with phage (5910 Phage&#8217;) and the 5910-R<sub>&#966;</sub> phenotype lacked the capsule (Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>A), and did not produce capsular polysaccharides with high molecular weight (Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>B). To investigate which gene might be differentially expressed between the groups that resulted in the phenotypic change, we performed bulk RNA sequencing and analysed differentially expressed genes within the KL52 locus, which is responsible for capsule synthesis in the parental 5910 strain. Although the 5910 Phage&#8217; and 5910-R<sub>&#966;</sub> clones were non-encapsulated, we did not observe any genes in the KL52 locus that were differently expressed between the groups (Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>C). Spike proteins of some phages can carry depolymerase activity, which degrades extracellular polysaccharides or capsular polysaccharides on the bacterial surface, facilitating the phages for the initial steps of host infection [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR65">65</xref>]. Thus, the tail spike protein of phage fBenAci003 was analysed for depolymerase activity with the Phage Depolymerase Finder PhageDPO [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>]. Indeed, the phage tail spike protein was predicted to carry a depolymerase with a probability of 99% (Table <xref rid="MOESM1" ref-type="media">S2</xref>). This suggested that the phage fBenAci003 degrades capsular polysaccharides of <italic toggle="yes">A. baumannii</italic> 5910 to initiate the infection.</p><p id="Par34">
<fig id="Fig5" position="float" orientation="portrait"><label>Fig.&#160;5</label><caption><p>Phage treatment induces morphological changes in <italic toggle="yes">A. baumannii</italic> 5910. <bold>A</bold> Capsule staining of <italic toggle="yes">A. baumannii</italic> 5910 phenotypes<bold>.</bold> Parental 5910 strain was preconditioned with 25% HIS (5910 HIS&#8217;), 25% NHS (5910 NHS&#8217;) or with phage fBenAci003 (5910 Phage&#8217;), while 5910-R<sub>&#966;</sub> and 5910-S<sub>&#966;</sub> were grown in LB overnight. Bacterial cultures were pelleted and stained with India ink and 1% Crystal violet. <bold>B</bold> Capsular polysaccharide extraction. Capsular polysaccharides were isolated from overnight bacterial cultures and stained with 0.1% Alcian Blue after separation with SDS-PAGE. <bold>C</bold> Transcriptome analysis of the KL52 locus in <italic toggle="yes">A. baumannii</italic> 5910 phenotypes. Bacterial mRNA was isolated and sequenced. Plots of four biological replicates and mean&#8201;&#177;&#8201;SEM are shown (n&#8201;=&#8201;4). Statistical analysis was performed with DESeq2 and Wald statistical test was used for comparison of means. <bold>D</bold> Analysis of extracted lipooligosaccharide (LOS). LOS were isolated from overnight cultures of the different <italic toggle="yes">A. baumannii</italic> 5910 phenotypes and silver stained after separation with SDS-PAGE. <bold>A</bold>, <bold>B</bold> and <bold>D</bold> are representative figures of two independent biological experiments</p></caption><graphic id="d33e1290" position="float" orientation="portrait" xlink:href="430_2025_852_Fig5_HTML.jpg"/></fig>
</p><p id="Par35">Furthermore, we isolated lipooligosaccharides (LOS) from the bacteria and stained them with silver. In addition to the downregulation of capsular polysaccharide expression in 5910-R<sub>&#966;</sub>, these bacteria also synthesised shorter LOS relative to the parental 5910 strain preconditioned with serum and the 5910-S<sub>&#966;</sub> clone, while 5910 Phage&#8217; had both versions of LOS (Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>D). The transcription levels of the genes within the outer core locus 1 (OCL1) that encodes enzymes catalysing the linkage of sugars to the outer core oligosaccharides of LOS and the genes involved in the inner core and lipidA synthesis were analysed. However, none of the genes were differently expressed between the groups (Fig. <xref rid="MOESM1" ref-type="media">S8</xref>A). Moreover, we analysed the expression levels of genes involved in other lipopolysaccharide (LPS) or LOS biosynthesis pathways. Interestingly, lipopolysaccharide export system permease, <italic toggle="yes">lptG</italic>, was significantly downregulated in the 5910-R<sub>&#966;</sub> clone (Fig. <xref rid="MOESM1" ref-type="media">S8</xref>B). Altogether, the results indicate that the capsular polysaccharide and longer LOS protect <italic toggle="yes">A. baumannii</italic> from complement-mediated killing, but at least one of the two is essential for phage infection.</p></sec><sec id="Sec22"><title>Transposon mutagenesis downregulates capsule synthesis in <italic toggle="yes">A. baumannii</italic></title><p id="Par36">Previously, it has been reported that <italic toggle="yes">A. baumannii</italic> undergoes spontaneous mutations upon treatment with phages [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR67">67</xref>]. To address whether phage- treatment led to spontaneous mutations within the KL52 locus, the genomes of the parental 5910 strain, 5910-R<sub>&#966;</sub> and 5910-S<sub>&#966;</sub> clones were sequenced, and a comparison of the KL52 locus was performed. The sequence alignments between the parental 5910 and 5910-R<sub>&#966;</sub> clones revealed that the gene glucose-6-phosphate isomerase (<italic toggle="yes">pgi</italic>) was disrupted with an insertion sequence in the non-encapsulated 5910-R<sub>&#966;</sub> clone (Fig.&#160;<xref rid="Fig6" ref-type="fig">6</xref>A). The mutation within <italic toggle="yes">pgi</italic> was further confirmed by amplifying and sequencing the local area of the insertion site (Fig.&#160;<xref rid="Fig6" ref-type="fig">6</xref>B). The 712&#160;bp insertion sequence was identified through BLAST as ISAba36 (accession number: <ext-link ext-link-type="pmc:entrez-nucleotide" xlink:href="MN735933.1">MN735933.1</ext-link>), which is a transposon and encodes the transposase TnpA. Similarly, ISAba36 was also obtained from the ISfinder database (accession number: <ext-link ext-link-type="pmc:entrez-nucleotide" xlink:href="KU667287">KU667287</ext-link>) and BLASTn sequence alignment showed 99% identity. Additionally, ISFinder identified TnpA to be a DDE-type transposase belonging to IS family IS1595 and the group IS1016. Flanking the <italic toggle="yes">tnp</italic>A gene, there were inverted repeats (IRs) with a sequence GGGGCTGTAGTAGAT (Fig.&#160;<xref rid="Fig6" ref-type="fig">6</xref>C). This sequence contains the consensus sequence GGGgctg found in IRs of IS1016 as reported in an earlier study [<xref ref-type="bibr" rid="CR68">68</xref>]. Remarkably, the integration of ISAba36 in <italic toggle="yes">pgi</italic> in the 5910-R<sub>&#966;</sub> sequence created a premature stop codon between the direct repeat and the left IR of ISAba36 (Fig.&#160;<xref rid="Fig6" ref-type="fig">6</xref>D). This suggests that downregulation of capsular polysaccharide expression could occur at the translational level of <italic toggle="yes">pgi</italic>.</p><p id="Par37">
<fig id="Fig6" position="float" orientation="portrait"><label>Fig.&#160;6</label><caption><p>Transposon mutagenesis disrupts the KL52 locus in the <italic toggle="yes">A. baumannii</italic> phage-resistant 5910 phenotype. <bold>A</bold> Sequence alignment of KL52 locus between different phenotypes. Genomic DNA was isolated from overnight cultures of parental 5910 strain, 5910-R<sub>&#966;</sub> and 5910-S<sub>&#966;</sub>. Sequenced genomes were assembled and the KL52 locus between the isolates was compared. Insertion sequence ISAba36 disrupting glucose-6-phosphate isomerase (<italic toggle="yes">pgi</italic>) in 5910-R<sub>&#966;</sub> was identified by BLAST and ISFinder. <bold>B</bold> Verification of insertion sequence in <italic toggle="yes">A. baumannii</italic> 5910-R<sub>&#966;</sub> clone. The local insertion region was amplified by PCR and separated in 2% agarose gel. The bands were extracted from the gel and sequenced. Representative gel picture of two independent biological replicates. <bold>C</bold> Schematic illustration of the mobile element, ISAba36, and transposon mutagenesis. Target site within <italic toggle="yes">pgi</italic> is duplicated upon integration of ISAba36 with its inherent transposase, TnpA. Upon deletion of the insertion sequence, duplicated target sites may remain as a footprint. <bold>D</bold> Insertion of ISAba36, generates a premature stop codon in <italic toggle="yes">pgi</italic> of the 5910-R<sub>&#966;</sub> clone. Schematic illustration of the original coding sequence and the mutated Pgi, and transposase A (TnpA) in <italic toggle="yes">A. baumannii</italic> 5910 phenotypes. Red arrows: inverted repeats of the mobile element ISAba36. Black asterisk: stop codon. <bold>E</bold> Whole-genome of <italic toggle="yes">A. baumannii</italic> 5910 parental strain and the identified mutations in the 5910-R<sub>&#966;</sub> and 5910-S<sub>&#966;</sub> clones. The mutations in the clones were located relative to the parental 5910 strain by using variant calling tool on PATRIC. Grey box: mutations in 5910-R<sub>&#966;</sub> clone. Yellow box: mutations in 5910-S<sub>&#966;</sub> clone</p></caption><graphic id="d33e1441" position="float" orientation="portrait" xlink:href="430_2025_852_Fig6_HTML.jpg"/></fig>
</p><p id="Par38">Upon insertion of the DDE transposon into the target site and repair of the broken DNA strands, direct repeats were formed on both sides of the integrated transposon (Fig.&#160;<xref rid="Fig6" ref-type="fig">6</xref>C). Generation of direct repeats can be useful for tracking past transposon mobility events, as they remain as a footprint in the excision site after the transposon has been removed [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]. As illustrated in Fig.&#160;<xref rid="Fig6" ref-type="fig">6</xref>C, direct repeats were found in the 5910-R<sub>&#966;</sub> sequence flanking the integrated ISAba36, with a sequence, TAACGTTT. Upon transposon excision, the direct repeats will often remain at the site, however, such duplication was not found in the <italic toggle="yes">pgi</italic> of 5910-S<sub>&#966;</sub> sequence. Indicating that 5910-R<sub>&#966;</sub> could revert to its original encapsulated phenotype through a scarless DNA repair mechanism when challenged with NHS. Importantly, although <italic toggle="yes">pgi</italic> remains intact in 5910-S<sub>&#966;</sub>, this clone carried mutations which were commonly found in 5910-R<sub>&#966;</sub>, but not in the parental 5910 strain (Fig.&#160;<xref rid="Fig6" ref-type="fig">6</xref>E, Table <xref rid="MOESM1" ref-type="media">S3</xref>), ruling out possible contamination from the parental 5910 strain.</p></sec></sec><sec id="Sec23"><title>Discussion</title><p id="Par39">In this study we observed that the combination of complement-preserved serum and phages totally abrogated the viability of different <italic toggle="yes">A. baumannii</italic> strains, reflecting a synergistic effect (Figs. <xref rid="Fig1" ref-type="fig">1</xref>C and <xref rid="MOESM1" ref-type="media">S1</xref>C). Initially, we hypothesised that the complement system may inhibit the phages from killing the bacteria, which has been demonstrated in a previous study showing that <italic toggle="yes">P. aeruginosa</italic> -specific phages having myovirus morphology were inhibited by C1q [<xref ref-type="bibr" rid="CR34">34</xref>]. However, in the same work, four phages having podovirus morphology were found to be insensitive to complement-mediated inhibition. The three phages used in this work, fBenAci001, fBenAci002 and fBenAci003, belong to the <italic toggle="yes">Autographiviridae</italic> family [<xref ref-type="bibr" rid="CR37">37</xref>] and are structurally podoviruses, which encouraged us to hypothesise that these phages would tolerate complement. Our promising results call for additional work regarding the effect of complement on phages representing different morphological and taxonomical groups. This work is needed for understanding the overall picture in phage-complement interactions, especially because of the potential therapeutic implications they may have during the era of progressively increasing problems related to antimicrobial resistance.</p><p id="Par40">Like many <italic toggle="yes">Acinetobacter</italic> spp., <italic toggle="yes">A. baumannii</italic> 5910 was resistant to complement-mediated killing and able to grow in 25% NHS (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>B and C). Although the parental 5910 strain was initially sensitive to phage fBenAci003, the strain rapidly adapted and became resistant to the phage in standard culture conditions (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>A). Interestingly, the phage-resistant 5910-R<sub>&#966;</sub> clone was rapidly killed by NHS (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>B), which concurs with previous reports on other <italic toggle="yes">A. baumannii</italic> phages [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR71">71</xref>]. Although complement is inactivated in HIS, the growth curves of the parental 5910 strain and 5910-R<sub>&#966;</sub> were retarded in 25% HIS condition relative to the medium control (Figs. <xref rid="Fig1" ref-type="fig">1</xref>B, <xref rid="Fig2" ref-type="fig">2</xref>C and D). Possibly, both phenotypes were sensitive to heat-stable proteins in serum, such as antimicrobial peptides, antibodies or C1q [<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR73">73</xref>]. Additionally, we verified the role of complement in clearing 5910-R<sub>&#966;</sub> by the ability of ravulizumab (anti-C5 antibody) to prevent bacterial lysis (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>E). The 5910-R<sub>&#966;</sub> clone also showed a higher level of C5b-9 deposition and an increased permeability (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>D and E). Altogether, the results show that the complement system is activated and kills the phage-resistant <italic toggle="yes">A. baumannii</italic> phenotype.</p><p id="Par41">Furthermore, we extended previous findings of phage-resistant <italic toggle="yes">A. baumannii</italic> becoming resensitised to serum complement by characterising the complement pathways that play a role in killing the different <italic toggle="yes">A. baumannii</italic> phenotypes. When all the three complement pathways were active, C5b-9 was more extensively formed on 5910-R<sub>&#966;</sub> at the 10&#160;min time-point relative to 5910 NHS&#8217; and 5910-S<sub>&#966;</sub> (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>A). In contrast, when the classical and lectin pathways were inhibited, 5910 NHS&#8217; and 5910-S<sub>&#966;</sub> showed a higher level of C5b-9 deposition over time compared to 5910-R<sub>&#966;</sub> (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>C). Importantly, 5910 NHS&#8217; and 5910-S<sub>&#966;</sub> induced high levels of soluble C5b-9 even when the classical and lectin pathways were inhibited (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>B and D). This indicated that the 5910 NHS&#8217; and 5910-S<sub>&#966;</sub> clone can escape the complement system by shedding C5b-9 from the bacterial surface. Although these observations strongly suggest that the classical and lectin pathway are important for the rapid generation of C5b-9 on 5910-R<sub>&#966;</sub>, we do not exclude the importance of the alternative pathway in killing this clone. When the 5910-R<sub>&#966;</sub> clone was cultivated at serum concentrations below 4%, the bacteria grew as well as under serum-free conditions (Fig. <xref rid="MOESM1" ref-type="media">S3</xref>). This suggests that the alternative complement pathway is involved in the killing of 5910-R<sub>&#966;</sub>, since at concentrations below 5% the activity of the alternative pathway becomes limited [<xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR75">75</xref>]. Possibly, the classical and lectin pathways are crucial for initial activation of the complement system, while the alternative pathway is necessary for amplifying the activation and further promoting activation of the terminal pathway. Notably, in a real-life situation complement activation would also boost phagocytosis by attracting and activating neutrophils to attack complement-opsonised bacteria.</p><p id="Par42">According to previous studies, <italic toggle="yes">Acinetobacter</italic> capsule is an important complement escape mechanism by shielding the outer membrane from C5b-9 deposition [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. In line with earlier findings [<xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR76">76</xref>], the 5910 Phage&#8217; and 5910-R<sub>&#966;</sub> phenotypes had indeed downregulated capsule expression (Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>A and B). Moreover, after exposure to the fBenAci003 phage, the length of the LOS of these bacteria became shorter compared to the 5910 LB, 5910 HIS&#8217;, 5910 NHS&#8217; and 5910-S<sub>&#966;</sub> phenotypes (Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>D). Notably, the expression level of capsular polysaccharides and longer LOS in 5910 NHS&#8217; and 5910-S<sub>&#966;</sub> also reflected their ability to activate the alternative pathway more rapidly than 5910-R<sub>&#966;</sub> (Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>C), as demonstrated in other bacterial species [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR78">78</xref>]. This morphological change had been observed previously [<xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR79">79</xref>], and suggests that longer LOS in 5910 might serve as a receptor for fBenAci003 to infect its host. In any case, the longer LOS might be advantageous for 5910 to evade the complement system, as the presence of longer LPS in <italic toggle="yes">A. baumannii</italic>, <italic toggle="yes">Salmonella</italic> spp, <italic toggle="yes">Coxiella burnetii</italic>, and <italic toggle="yes">Klebsiella pneumoniae</italic> protects these bacteria from complement-mediated killing [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR80">80</xref>&#8211;<xref ref-type="bibr" rid="CR83">83</xref>]. Certainly, further studies are required to estimate the relative contributions of the capsular polysaccharides and LOS in complement evasion and phage fBenAci003 sensitivity of <italic toggle="yes">A. baumannii</italic>.</p><p id="Par43">Recently, it has been reported that phage-resistant <italic toggle="yes">P. aeruginosa</italic> with a defect in the LPS synthesis machinery, generated lower levels of soluble C5b-9 and was susceptible to killing by serum complement [<xref ref-type="bibr" rid="CR84">84</xref>]. A similar phenomenon was also observed in our study (Figs. <xref rid="Fig3" ref-type="fig">3</xref>F and <xref rid="Fig5" ref-type="fig">5</xref>D). Additionally, we demonstrated that a shorter LOS correlated with the more abundant deposition of C5b-9 and membrane permeability (Figs. <xref rid="Fig3" ref-type="fig">3</xref>D, E and <xref rid="Fig5" ref-type="fig">5</xref>D). Notably, the 5910 Phage&#8217; had longer and shorter LOS, but more C5b-9 deposited to the 5910-R<sub>&#966;</sub> clone, which only synthesised shorter LOS. Altogether our results indicate that the complement system is activated by all <italic toggle="yes">A. baumannii</italic> phenotypes. However, the expression of capsular polysaccharides and longer LOS prevented efficient insertion of the C5b-9 complex on the bacterial outer membrane. Instead of membrane insertion, the C5b-9 complex became shed to the environment.</p><p id="Par44">Interestingly, the tail spike proteins of the <italic toggle="yes">Acinetobacter</italic> phages often carry depolymerase activity, which can cleave capsular polysaccharides. In previous studies, treatment of capsular polysaccharides of the targeted hosts with purified depolymerases from the <italic toggle="yes">A. baumannii</italic> phages led to serum sensitisation [<xref ref-type="bibr" rid="CR85">85</xref>&#8211;<xref ref-type="bibr" rid="CR87">87</xref>]. Given that the spike protein of fBenAci003 phage has been predicted to have depolymerase activity (Table <xref rid="MOESM1" ref-type="media">S2</xref>) and none of the genes in the K locus were significantly differentially expressed at the transcriptomic level (Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>C), the phage depolymerase might potentially have degraded the capsular polysaccharide, making these bacteria become sensitive to complement. However, the quantity of the enzyme in assays using purified depolymerase is in general higher and the degradation of the bacterial capsule more efficient compared to the depolymerase that is part of the phage tail. Moreover, the MOIs that were used in this study were relatively low, suggesting that the phages probably used the depolymerase to recognise the capsular polysaccharide as a primarily receptor, and their concentration may not have been sufficient enough to completely degrade the capsule during the infection of the host.</p><p id="Par45">To completely avoid phage attack, the bacteria became resistant to the phage by downregulating capsule synthesis through transposon mutagenesis. As a response to selection pressure, the chromosomal DNA of <italic toggle="yes">A. baumannii</italic> can undergo spontaneous mutations [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR71">71</xref>, <xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR88">88</xref>]. Disruption of the K locus through the insertion of transposases, IS4 and IS5, has previously been observed in phage-resistant <italic toggle="yes">A. baumannii</italic> strains [<xref ref-type="bibr" rid="CR76">76</xref>]. In our study, we report transposon mutagenesis as a phage-resistance mechanism in <italic toggle="yes">A. baumannii</italic> 5910, where the insertion of ISAba36 at <italic toggle="yes">pgi</italic> could lead to the downregulation of capsule expression (Figs. <xref rid="Fig5" ref-type="fig">5</xref>, <xref rid="Fig6" ref-type="fig">6</xref>A and B). Although the <italic toggle="yes">pgi</italic> mRNA expression level was not differentially expressed between the phenotypes, a premature stop codon was observed in <italic toggle="yes">pgi</italic> upon integration of ISAba36 (Figs. <xref rid="Fig5" ref-type="fig">5</xref>C and <xref rid="Fig6" ref-type="fig">6</xref>D). This indicates that the mutation leads to a truncated Pgi without the Lys519 residue, which is one of the important active sites in the C-terminal part of Pgi [<xref ref-type="bibr" rid="CR89">89</xref>] (UniProt accession ID: <ext-link ext-link-type="pmc:entrez-protein" xlink:href="B0VMS2">B0VMS2</ext-link>). Thus, truncation of Pgi most probably reduced or completely abolished its enzymatic activity, thereby leading to downregulation of capsule synthesis.</p><p id="Par46">Previous studies have shown that genes at the outer core locus is often downregulated or mutated in <italic toggle="yes">A. baumannii</italic> after phage treatment, which potentially could result to the production of truncated LOS [<xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR90">90</xref>]. Despite the fact that phage treatment led to truncated LOS production in <italic toggle="yes">A. baumannii</italic> 5910, we did not observe any mutations nor downregulation of transcription of genes within the OCL1 locus (Fig. <xref rid="MOESM1" ref-type="media">S8</xref>A). Given that depolymerases can also degrade LPS [<xref ref-type="bibr" rid="CR91">91</xref>, <xref ref-type="bibr" rid="CR92">92</xref>], we do not exclude the possibility that fBenAci003 might have cleaved the LOS of the host. Certainly, changes in other LPS or LOS biosynthesis pathways could also affect the LOS composition. Among these pathways, the Lpt machinery is important for transportation of LPS to the outer membrane, where LptF and LptG are responsible for the extraction of LPS from the bacterial inner membrane and delivery of the LPS molecule to Lpt proteins in the periplasm and outer membrane [<xref ref-type="bibr" rid="CR93">93</xref>, <xref ref-type="bibr" rid="CR94">94</xref>]. Indeed, the 5910-R<sub>&#966;</sub> clone significantly downregulated the transcription of <italic toggle="yes">lptG</italic>, but we did not observe a similar trend in the 5910 Phage&#8217; phenotype (Fig. <xref rid="MOESM1" ref-type="media">S8</xref>B). Possibly, truncation of LOS in the 5910 Phage&#8217; phenotype is due to downregulation of genes in other biosynthesis pathways, or degradation by phage depolymerase. Furthermore, we confirmed that <italic toggle="yes">lptG</italic> was not mutated in the 5910-R<sub>&#966;</sub> clone. Hence, the relation of <italic toggle="yes">lptG</italic> and the functional outcome of LOS composition in <italic toggle="yes">A. baumannii</italic> needs to be assessed through additional studies in the future. As Pgi catalyses the interconversion of glucose-6-phosphate to fructose-6-phosphate, we speculate that the mutation of this enzyme might indirectly affect the synthesis of LOS in <italic toggle="yes">A. baumannii</italic>, by causing an imbalance in the carbohydrate metabolism or in the production of substrates for LOS synthesis. In line with previous observations [<xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR90">90</xref>], downregulation of both capsular polysaccharides and LOS seems to be essential for the fBenAci003 phage to recognise <italic toggle="yes">A. baumannii</italic> 5910. However, further studies are required to confirm whether the loss of capsule or longer LOS affects the adsorption of phages to the host and pinpoint which serves as a primary receptor for fBenAci003 phage.</p><p id="Par47">Transposon insertion typically leads to target-site duplication, flanking the termini of the transposon. Upon excision of the transposon, target-site duplication often remains as a footprint, which can be used for tracking transposon activities [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]. However, seamless repair of the DNA after the excision of the transposon has also been reported, but most of these observations have been made with eukaryotic transposons [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]. To the best of our knowledge, homologous recombination and the RecBCD complex have been reported as repair mechanisms in prokaryotes during transposon transfer to the target DNA [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR70">70</xref>], while seamless DNA repair mechanisms after transposon excision have been less intensely studied. Recently, seamless DNA repair has been reported in <italic toggle="yes">A. baumannii</italic>, showing that capsule production can be restored after prolonged exposure to antibiotics [<xref ref-type="bibr" rid="CR95">95</xref>]. Similarly, our study demonstrated that the non-encapsulated phenotype could revert to an encapsulated phenotype after serum exposure through the excision of the mobile element ISAba36 from <italic toggle="yes">pgi</italic> (Fig.&#160;<xref rid="Fig6" ref-type="fig">6</xref>). To eliminate the possibility that 5910-S<sub>&#966;</sub> is contaminated with the parental 5910 strain, 5910-S<sub>&#966;</sub> were compared with 5910-R<sub>&#966;</sub> and parental 5910 for mutations that were commonly shared. Indeed, 5910-S<sub>&#966;</sub> carried mutations that were found in the 5910-R<sub>&#966;</sub> clone, but not in the parental 5910 strain (Fig.&#160;<xref rid="Fig6" ref-type="fig">6</xref>E and Table <xref rid="MOESM1" ref-type="media">S3</xref>). This supported the possibility that 5910-S<sub>&#966;</sub> might have vertically inherited these mutations from the 5910-R<sub>&#966;</sub> clone, and the DNA was repaired seamlessly after transposon excision from <italic toggle="yes">pgi</italic>. Together with the observations of shared similar features between the parental 5910 strain and the 5910-S<sub>&#966;</sub> clone (Figs. <xref rid="MOESM1" ref-type="media">S2</xref>, <xref rid="MOESM1" ref-type="media">S4</xref> and <xref rid="Fig5" ref-type="fig">5</xref>), our findings indicate that transposon mutagenesis is a reversible process that can be induced through prolonged serum exposure, in which <italic toggle="yes">A. baumannii</italic> 5910 can adapt to phage or NHS conditions.</p><p id="Par48">On the other hand, the absence of target-site duplication at <italic toggle="yes">pgi</italic> in the 5910-S<sub>&#966;</sub> clone supports the idea of the existence of heterogenous subpopulations and that the selection pressure can skew the distribution towards a predominant population with a distinct phenotype. Phase variation has been studied in <italic toggle="yes">A. baumannii</italic> and contributes to population diversity, where the subpopulations exhibit different morphologies and virulence [<xref ref-type="bibr" rid="CR96">96</xref>&#8211;<xref ref-type="bibr" rid="CR99">99</xref>]. Nevertheless, our observation of large variation of C5b-9 deposition and viability in serum of the parental 5910 strain also reflects heterogeneity (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>B and C). By means of preconditioning the parental 5910 strain with NHS or with the fBenAci003 phage, their viability in serum and C5b-9 deposition were less variable, apparently as a result of homogeneous population enrichment (Figs. <xref rid="Fig3" ref-type="fig">3</xref>D, <xref rid="MOESM1" ref-type="media">S6</xref> and <xref rid="MOESM1" ref-type="media">S7</xref>).</p><p id="Par49">Currently, case studies have reported the use of phages to treat infections caused by multidrug-resistant <italic toggle="yes">A. baumannii</italic>. In certain instances, <italic toggle="yes">A. baumannii</italic> infections have been successfully cleared [<xref ref-type="bibr" rid="CR100">100</xref>&#8211;<xref ref-type="bibr" rid="CR104">104</xref>]. Notably, during the time course of phage therapy of a patient with necrotising pancreatitis complicated by multidrug-resistant <italic toggle="yes">A. baumannii</italic>, the bacteria developed resistance to the phages that were administered to the patient. Further characterisation of the phage-resistant isolates showed a gradual morphological change towards a non-encapsulated phenotype which carried mutated <italic toggle="yes">gtr76</italic> within the KL116 locus [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR100">100</xref>]. We observed a similar phenomenon in vitro, when the 5910 strain became resistant to phages due to transposon mutagenesis in <italic toggle="yes">pgi</italic> (Figs. <xref rid="MOESM1" ref-type="media">S2</xref>, <xref rid="Fig5" ref-type="fig">5</xref> and <xref rid="Fig6" ref-type="fig">6</xref>). Thus, with the concern for phenotypic variations in <italic toggle="yes">A. baumannii</italic>, we emphasise the importance of preconditioning clinical isolates of bacteria in a way that mimics in vivo settings. This would be relevant during the development of alternative therapeutic means and for evaluating conventional and combinatorial therapy outcomes. These conditions should be expanded to study the efficacy of various antibiotics and the sensitisation of bacteria under phage and complement selection. In this regard, our study highlights the synergy between phages and the complement system in clearing <italic toggle="yes">A. baumannii</italic>. Importantly, the synergism between the complement system and phages in killing the tested <italic toggle="yes">A. baumannii</italic> strains, as observed in our study, may also indicate a preserved bactericidal effect against many other <italic toggle="yes">A. baumannii</italic> strains. Knowing that the phages carry depolymerase activity (Table <xref rid="MOESM1" ref-type="media">S2</xref>), suggests that they can degrade the capsular polysaccharide on the bacterial surface, which allows the complement C5b-9 complex to be deposited more readily on the outer membrane.</p><p id="Par50">During an infection and tissue damage, complement becomes activated and can become depleted from the area of infection. Also, there may not be enough complement in wounds, body cavities or other areas. Therefore, supplying these areas with fresh complement together with phages could be vital for clearing an infection caused by multidrug-resistant bacteria. Furthermore, supplying the areas with anti-bacterial antibodies simultaneously&#8212;either separately as passive antibodies or in immune serum with complement&#8212;would boost the killing efficacy of complement. Using endogenous patient serum could be effective, especially when the bacteria exist in their non-encapsulated phenotype as a predominant subpopulation. Studies have shown that the use of antibodies could be a potential therapy to treat infections caused by <italic toggle="yes">A. baumannii</italic> [<xref ref-type="bibr" rid="CR105">105</xref>&#8211;<xref ref-type="bibr" rid="CR107">107</xref>]. However, due to the diversity of capsular polysaccharides in <italic toggle="yes">A. baumannii</italic>, the development of capsule-targeting monoclonal antibodies for therapeutic use would be challenging [<xref ref-type="bibr" rid="CR108">108</xref>, <xref ref-type="bibr" rid="CR109">109</xref>]. On the other hand, the conserved outer membrane protein, OmpA, is considered as a more appropriate vaccine candidate [<xref ref-type="bibr" rid="CR110">110</xref>], though, capsular polysaccharides can prevent antibodies from binding to OmpA leading to a reduced efficacy [<xref ref-type="bibr" rid="CR109">109</xref>]. We envision that immunotherapy can be boosted by phages that degrade capsular polysaccharides, exposing OmpA or other targets to immune serum containing both anti-bacterial antibodies and complement.</p></sec><sec id="Sec197" sec-type="supplementary-material"><title>Supplementary Information</title><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xlink:href="430_2025_852_MOESM1_ESM.pdf" position="float" orientation="portrait"><caption><p>Supplementary Material 1</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>This study was supported by the EU MSCA-ITN EJD project Corvos (860044), The Sigrid Jus&#233;lius Foundation (4709553), Helsinki University Hospital Funds (TYH2019311, TYH2023322). We thank Prof. Mikael Skurnik, MSc Henni Tuomala, MSc Anna Kolsi and Dr. Katarzyna Leskinen from the University of Helsinki (Finland) and Prof. Dr.-Ing Jochen Schmid from the University of M&#252;nster (Germany) for their advice, technical support and stimulating discussions. Schematics were created with Geneious, Rstudio, Proksee and BioRender.com.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>C.C., J.K., S.K., and S.M. designed research; C.C., E.K.-D., and V.D. performed research; C.C., S.P., S.N.M., A.M., and S.K. analyzed data; and C.C., E.K.-D, S.K. and S.M. wrote the main manuscript text. All authors reviewed the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding provided by University of Helsinki (including Helsinki University Central Hospital).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>For the whole genome and RNAseq data, all can be retrieved through BioProject: PRJNA1074513 in GenBank. The raw data will be publically available once the manuscript is accepted. For the moment, the raw data can be reviewed through the following link: <ext-link ext-link-type="uri" xlink:href="https://data.mendeley.com/preview/z59ccd4dp5?a=7333d928-4824-4ac5-8e48-ca447f68b62f">https://data.mendeley.com/preview/z59ccd4dp5?a=7333d928-4824-4ac5-8e48-ca447f68b62f</ext-link>.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par51">The authors declare no conflict of interest.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tacconelli</surname><given-names>E</given-names></name><name name-style="western"><surname>Magrini</surname><given-names>N</given-names></name></person-group><article-title>Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics</article-title><source>World Health Organ</source><year>2017</year><volume>43</volume><fpage>348</fpage><lpage>365</lpage></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Tacconelli E, Magrini N (2017) Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. World Health Organ 43:348&#8211;365</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Antunes</surname><given-names>LCS</given-names></name><name name-style="western"><surname>Visca</surname><given-names>P</given-names></name><name name-style="western"><surname>Towner</surname><given-names>KJ</given-names></name></person-group><article-title><italic toggle="yes">Acinetobacter baumannii</italic>: evolution of a global pathogen</article-title><source>Pathog Dis</source><year>2014</year><volume>71</volume><fpage>292</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1111/2049-632X.12125</pub-id><pub-id pub-id-type="pmid">24376225</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Antunes LCS, Visca P, Towner KJ (2014) <italic toggle="yes">Acinetobacter baumannii</italic>: evolution of a global pathogen. Pathog Dis 71:292&#8211;301. 10.1111/2049-632X.12125<pub-id pub-id-type="pmid">24376225</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/2049-632X.12125</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morris</surname><given-names>FC</given-names></name><name name-style="western"><surname>Dexter</surname><given-names>C</given-names></name><name name-style="western"><surname>Kostoulias</surname><given-names>X</given-names></name><name name-style="western"><surname>Uddin</surname><given-names>MI</given-names></name><name name-style="western"><surname>Peleg</surname><given-names>AY</given-names></name></person-group><article-title>The mechanisms of disease caused by <italic toggle="yes">Acinetobacter baumannii</italic></article-title><source>Front Microbiol</source><year>2019</year><volume>10</volume><fpage>1601</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2019.01601</pub-id><pub-id pub-id-type="pmid">31379771</pub-id><pub-id pub-id-type="pmcid">PMC6650576</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Morris FC, Dexter C, Kostoulias X, Uddin MI, Peleg AY (2019) The mechanisms of disease caused by <italic toggle="yes">Acinetobacter baumannii</italic>. Front Microbiol 10:1601. 10.3389/fmicb.2019.01601<pub-id pub-id-type="pmid">31379771</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmicb.2019.01601</pub-id><pub-id pub-id-type="pmcid">PMC6650576</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kyriakidis</surname><given-names>I</given-names></name><name name-style="western"><surname>Vasileiou</surname><given-names>E</given-names></name><name name-style="western"><surname>Pana</surname><given-names>ZD</given-names></name><name name-style="western"><surname>Tragiannidis</surname><given-names>A</given-names></name></person-group><article-title><italic toggle="yes">Acinetobacter baumannii</italic> antibiotic resistance mechanisms</article-title><source>Pathogens</source><year>2021</year><volume>10</volume><fpage>373</fpage><pub-id pub-id-type="doi">10.3390/pathogens10030373</pub-id><pub-id pub-id-type="pmid">33808905</pub-id><pub-id pub-id-type="pmcid">PMC8003822</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Kyriakidis I, Vasileiou E, Pana ZD, Tragiannidis A (2021) <italic toggle="yes">Acinetobacter baumannii</italic> antibiotic resistance mechanisms. Pathogens 10:373. 10.3390/pathogens10030373<pub-id pub-id-type="pmid">33808905</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/pathogens10030373</pub-id><pub-id pub-id-type="pmcid">PMC8003822</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>C-R</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name><name name-style="western"><surname>Park</surname><given-names>M</given-names></name><name name-style="western"><surname>Park</surname><given-names>KS</given-names></name><name name-style="western"><surname>Bae</surname><given-names>IK</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YB</given-names></name><etal/></person-group><article-title>Biology of <italic toggle="yes">Acinetobacter baumannii</italic>: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options</article-title><source>Front Cell Infect Microbiol</source><year>2017</year><pub-id pub-id-type="doi">10.3389/fcimb.2017.00055</pub-id><pub-id pub-id-type="pmid">28348979</pub-id><pub-id pub-id-type="pmcid">PMC5346588</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Lee C-R, Lee JH, Park M, Park KS, Bae IK, Kim YB et al (2017) Biology of <italic toggle="yes">Acinetobacter baumannii</italic>: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol. 10.3389/fcimb.2017.00055<pub-id pub-id-type="pmid">28348979</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcimb.2017.00055</pub-id><pub-id pub-id-type="pmcid">PMC5346588</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rooijakkers</surname><given-names>SHM</given-names></name><name name-style="western"><surname>van Strijp</surname><given-names>JAG</given-names></name></person-group><article-title>Bacterial complement evasion</article-title><source>Mol Immunol</source><year>2007</year><volume>44</volume><fpage>23</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2006.06.011</pub-id><pub-id pub-id-type="pmid">16875737</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Rooijakkers SHM, van Strijp JAG (2007) Bacterial complement evasion. Mol Immunol 44:23&#8211;32. 10.1016/j.molimm.2006.06.011<pub-id pub-id-type="pmid">16875737</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molimm.2006.06.011</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>H&#233;ja</surname><given-names>D</given-names></name><name name-style="western"><surname>Kocsis</surname><given-names>A</given-names></name><name name-style="western"><surname>Dob&#243;</surname><given-names>J</given-names></name><name name-style="western"><surname>Szil&#225;gyi</surname><given-names>K</given-names></name><name name-style="western"><surname>Sz&#225;sz</surname><given-names>R</given-names></name><name name-style="western"><surname>Z&#225;vodszky</surname><given-names>P</given-names></name><etal/></person-group><article-title>Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2</article-title><source>Proc Natl Acad Sci USA</source><year>2012</year><volume>109</volume><fpage>10498</fpage><lpage>10503</lpage><pub-id pub-id-type="doi">10.1073/pnas.1202588109</pub-id><pub-id pub-id-type="pmid">22691502</pub-id><pub-id pub-id-type="pmcid">PMC3387078</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">H&#233;ja D, Kocsis A, Dob&#243; J, Szil&#225;gyi K, Sz&#225;sz R, Z&#225;vodszky P et al (2012) Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2. Proc Natl Acad Sci USA 109:10498&#8211;10503. 10.1073/pnas.1202588109<pub-id pub-id-type="pmid">22691502</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1202588109</pub-id><pub-id pub-id-type="pmcid">PMC3387078</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Merle</surname><given-names>NS</given-names></name><name name-style="western"><surname>Church</surname><given-names>SE</given-names></name><name name-style="western"><surname>Fremeaux-Bacchi</surname><given-names>V</given-names></name><name name-style="western"><surname>Roumenina</surname><given-names>LT</given-names></name></person-group><article-title>Complement system part I-molecular mechanisms of activation and regulation</article-title><source>Front Immunol</source><year>2015</year><volume>6</volume><fpage>262</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2015.00262</pub-id><pub-id pub-id-type="pmid">26082779</pub-id><pub-id pub-id-type="pmcid">PMC4451739</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT (2015) Complement system part I-molecular mechanisms of activation and regulation. Front Immunol 6:262. 10.3389/fimmu.2015.00262<pub-id pub-id-type="pmid">26082779</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2015.00262</pub-id><pub-id pub-id-type="pmcid">PMC4451739</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zwarthoff</surname><given-names>SA</given-names></name><name name-style="western"><surname>Berends</surname><given-names>ETM</given-names></name><name name-style="western"><surname>Mol</surname><given-names>S</given-names></name><name name-style="western"><surname>Ruyken</surname><given-names>M</given-names></name><name name-style="western"><surname>Aerts</surname><given-names>PC</given-names></name><name name-style="western"><surname>J&#243;zsi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Functional characterization of alternative and classical pathway C3/C5 convertase activity and inhibition using purified models</article-title><source>Front Immunol</source><year>2018</year><pub-id pub-id-type="doi">10.3389/fimmu.2018.01691</pub-id><pub-id pub-id-type="pmid">30083158</pub-id><pub-id pub-id-type="pmcid">PMC6064732</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Zwarthoff SA, Berends ETM, Mol S, Ruyken M, Aerts PC, J&#243;zsi M et al (2018) Functional characterization of alternative and classical pathway C3/C5 convertase activity and inhibition using purified models. Front Immunol. 10.3389/fimmu.2018.01691<pub-id pub-id-type="pmid">30083158</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2018.01691</pub-id><pub-id pub-id-type="pmcid">PMC6064732</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doorduijn</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Heesterbeek</surname><given-names>DAC</given-names></name><name name-style="western"><surname>Ruyken</surname><given-names>M</given-names></name><name name-style="western"><surname>de Haas</surname><given-names>CJC</given-names></name><name name-style="western"><surname>Stapels</surname><given-names>DAC</given-names></name><name name-style="western"><surname>Aerts</surname><given-names>PC</given-names></name><etal/></person-group><article-title>Polymerization of C9 enhances bacterial cell envelope damage and killing by membrane attack complex pores</article-title><source>PLoS Pathog</source><year>2021</year><volume>17</volume><fpage>e1010051</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1010051</pub-id><pub-id pub-id-type="pmid">34752492</pub-id><pub-id pub-id-type="pmcid">PMC8604303</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Doorduijn DJ, Heesterbeek DAC, Ruyken M, de Haas CJC, Stapels DAC, Aerts PC et al (2021) Polymerization of C9 enhances bacterial cell envelope damage and killing by membrane attack complex pores. PLoS Pathog 17:e1010051. 10.1371/journal.ppat.1010051<pub-id pub-id-type="pmid">34752492</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.ppat.1010051</pub-id><pub-id pub-id-type="pmcid">PMC8604303</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pathak</surname><given-names>A</given-names></name><name name-style="western"><surname>Bergstrand</surname><given-names>J</given-names></name><name name-style="western"><surname>Sender</surname><given-names>V</given-names></name><name name-style="western"><surname>Spelmink</surname><given-names>L</given-names></name><name name-style="western"><surname>Aschtgen</surname><given-names>M-S</given-names></name><name name-style="western"><surname>Muschiol</surname><given-names>S</given-names></name><etal/></person-group><article-title>Factor H binding proteins protect division septa on encapsulated <italic toggle="yes">Streptococcus pneumoniae</italic> against complement C3b deposition and amplification</article-title><source>Nat Commun</source><year>2018</year><volume>9</volume><fpage>3398</fpage><pub-id pub-id-type="doi">10.1038/s41467-018-05494-w</pub-id><pub-id pub-id-type="pmid">30139996</pub-id><pub-id pub-id-type="pmcid">PMC6107515</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Pathak A, Bergstrand J, Sender V, Spelmink L, Aschtgen M-S, Muschiol S et al (2018) Factor H binding proteins protect division septa on encapsulated <italic toggle="yes">Streptococcus pneumoniae</italic> against complement C3b deposition and amplification. Nat Commun 9:3398. 10.1038/s41467-018-05494-w<pub-id pub-id-type="pmid">30139996</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-018-05494-w</pub-id><pub-id pub-id-type="pmcid">PMC6107515</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dieudonn&#233;-Vatran</surname><given-names>A</given-names></name><name name-style="western"><surname>Krentz</surname><given-names>S</given-names></name><name name-style="western"><surname>Blom</surname><given-names>AM</given-names></name><name name-style="western"><surname>Meri</surname><given-names>S</given-names></name><name name-style="western"><surname>Henriques-Normark</surname><given-names>B</given-names></name><name name-style="western"><surname>Riesbeck</surname><given-names>K</given-names></name><etal/></person-group><article-title>Clinical isolates of <italic toggle="yes">Streptococcus pneumoniae</italic> bind the complement inhibitor C4b-binding protein in a PspC allele-dependent fashion</article-title><source>J Immunol</source><year>2009</year><volume>182</volume><fpage>7865</fpage><lpage>7877</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0802376</pub-id><pub-id pub-id-type="pmid">19494311</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Dieudonn&#233;-Vatran A, Krentz S, Blom AM, Meri S, Henriques-Normark B, Riesbeck K et al (2009) Clinical isolates of <italic toggle="yes">Streptococcus pneumoniae</italic> bind the complement inhibitor C4b-binding protein in a PspC allele-dependent fashion. J Immunol 182:7865&#8211;7877. 10.4049/jimmunol.0802376<pub-id pub-id-type="pmid">19494311</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.0802376</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>SR</given-names></name><name name-style="western"><surname>Menon</surname><given-names>SS</given-names></name><name name-style="western"><surname>Cortes</surname><given-names>C</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>VP</given-names></name></person-group><article-title>Hijacking factor H for complement immune evasion</article-title><source>Front Immunol</source><year>2021</year><pub-id pub-id-type="doi">10.3389/fimmu.2021.602277</pub-id><pub-id pub-id-type="pmid">33717083</pub-id><pub-id pub-id-type="pmcid">PMC7947212</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Moore SR, Menon SS, Cortes C, Ferreira VP (2021) Hijacking factor H for complement immune evasion. Front Immunol. 10.3389/fimmu.2021.602277<pub-id pub-id-type="pmid">33717083</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2021.602277</pub-id><pub-id pub-id-type="pmcid">PMC7947212</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ermert</surname><given-names>D</given-names></name><name name-style="western"><surname>Blom</surname><given-names>AM</given-names></name></person-group><article-title>C4b-binding protein: the good, the bad and the deadly. Novel functions of an old friend</article-title><source>Immunol Lett</source><year>2016</year><volume>169</volume><fpage>82</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.imlet.2015.11.014</pub-id><pub-id pub-id-type="pmid">26658464</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Ermert D, Blom AM (2016) C4b-binding protein: the good, the bad and the deadly. Novel functions of an old friend. Immunol Lett 169:82&#8211;92. 10.1016/j.imlet.2015.11.014<pub-id pub-id-type="pmid">26658464</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.imlet.2015.11.014</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>SW</given-names></name><name name-style="western"><surname>Choi</surname><given-names>CH</given-names></name><name name-style="western"><surname>Moon</surname><given-names>DC</given-names></name><name name-style="western"><surname>Jin</surname><given-names>JS</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JH</given-names></name><name name-style="western"><surname>Shin</surname><given-names>J-H</given-names></name><etal/></person-group><article-title>Serum resistance of <italic toggle="yes">Acinetobacter baumannii</italic> through the binding of factor H to outer membrane proteins</article-title><source>FEMS Microbiol Lett</source><year>2009</year><volume>301</volume><fpage>224</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6968.2009.01820.x</pub-id><pub-id pub-id-type="pmid">19878322</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Kim SW, Choi CH, Moon DC, Jin JS, Lee JH, Shin J-H et al (2009) Serum resistance of <italic toggle="yes">Acinetobacter baumannii</italic> through the binding of factor H to outer membrane proteins. FEMS Microbiol Lett 301:224&#8211;231. 10.1111/j.1574-6968.2009.01820.x<pub-id pub-id-type="pmid">19878322</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1574-6968.2009.01820.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>King</surname><given-names>LB</given-names></name><name name-style="western"><surname>Swiatlo</surname><given-names>E</given-names></name><name name-style="western"><surname>Swiatlo</surname><given-names>A</given-names></name><name name-style="western"><surname>McDaniel</surname><given-names>LS</given-names></name></person-group><article-title>Serum resistance and biofilm formation in clinical isolates of <italic toggle="yes">Acinetobacter baumannii</italic></article-title><source>FEMS Immunol Med Microbiol</source><year>2009</year><volume>55</volume><fpage>414</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1111/j.1574-695X.2009.00538.x</pub-id><pub-id pub-id-type="pmid">19220466</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">King LB, Swiatlo E, Swiatlo A, McDaniel LS (2009) Serum resistance and biofilm formation in clinical isolates of <italic toggle="yes">Acinetobacter baumannii</italic>. FEMS Immunol Med Microbiol 55:414&#8211;421. 10.1111/j.1574-695X.2009.00538.x<pub-id pub-id-type="pmid">19220466</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1574-695X.2009.00538.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Magda</surname><given-names>M</given-names></name><name name-style="western"><surname>Bettoni</surname><given-names>S</given-names></name><name name-style="western"><surname>Laabei</surname><given-names>M</given-names></name><name name-style="western"><surname>Fairley</surname><given-names>D</given-names></name><name name-style="western"><surname>Russo</surname><given-names>TA</given-names></name><name name-style="western"><surname>Riesbeck</surname><given-names>K</given-names></name><etal/></person-group><article-title>Clinical isolates of <italic toggle="yes">Acinetobacter</italic> spp. are highly serum resistant despite efficient recognition by the complement system</article-title><source>Front Immunol</source><year>2022</year><pub-id pub-id-type="doi">10.3389/fimmu.2022.814193</pub-id><pub-id pub-id-type="pmid">35173727</pub-id><pub-id pub-id-type="pmcid">PMC8841485</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Magda M, Bettoni S, Laabei M, Fairley D, Russo TA, Riesbeck K et al (2022) Clinical isolates of <italic toggle="yes">Acinetobacter</italic> spp. are highly serum resistant despite efficient recognition by the complement system. Front Immunol. 10.3389/fimmu.2022.814193<pub-id pub-id-type="pmid">35173727</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2022.814193</pub-id><pub-id pub-id-type="pmcid">PMC8841485</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koenigs</surname><given-names>A</given-names></name><name name-style="western"><surname>Stahl</surname><given-names>J</given-names></name><name name-style="western"><surname>Averhoff</surname><given-names>B</given-names></name><name name-style="western"><surname>G&#246;ttig</surname><given-names>S</given-names></name><name name-style="western"><surname>Wichelhaus</surname><given-names>TA</given-names></name><name name-style="western"><surname>Wallich</surname><given-names>R</given-names></name><etal/></person-group><article-title>CipA of <italic toggle="yes">Acinetobacter baumannii</italic> is a novel plasminogen binding and complement inhibitory protein</article-title><source>J Infect Dis</source><year>2016</year><volume>213</volume><fpage>1388</fpage><lpage>1399</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiv601</pub-id><pub-id pub-id-type="pmid">26681776</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Koenigs A, Stahl J, Averhoff B, G&#246;ttig S, Wichelhaus TA, Wallich R et al (2016) CipA of <italic toggle="yes">Acinetobacter baumannii</italic> is a novel plasminogen binding and complement inhibitory protein. J Infect Dis 213:1388&#8211;1399. 10.1093/infdis/jiv601<pub-id pub-id-type="pmid">26681776</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/jiv601</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koenigs</surname><given-names>A</given-names></name><name name-style="western"><surname>Zipfel</surname><given-names>PF</given-names></name><name name-style="western"><surname>Kraiczy</surname><given-names>P</given-names></name></person-group><article-title>Translation elongation factor Tuf of <italic toggle="yes">Acinetobacter baumannii</italic> is a plasminogen-binding protein</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><fpage>e0134418</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0134418</pub-id><pub-id pub-id-type="pmid">26230848</pub-id><pub-id pub-id-type="pmcid">PMC4521846</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Koenigs A, Zipfel PF, Kraiczy P (2015) Translation elongation factor Tuf of <italic toggle="yes">Acinetobacter baumannii</italic> is a plasminogen-binding protein. PLoS ONE 10:e0134418. 10.1371/journal.pone.0134418<pub-id pub-id-type="pmid">26230848</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0134418</pub-id><pub-id pub-id-type="pmcid">PMC4521846</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ries</surname><given-names>JI</given-names></name><name name-style="western"><surname>He&#223;</surname><given-names>M</given-names></name><name name-style="western"><surname>Nouri</surname><given-names>N</given-names></name><name name-style="western"><surname>Wichelhaus</surname><given-names>TA</given-names></name><name name-style="western"><surname>G&#246;ttig</surname><given-names>S</given-names></name><name name-style="western"><surname>Falcone</surname><given-names>FH</given-names></name><etal/></person-group><article-title><italic toggle="yes">CipA</italic> mediates complement resistance of <italic toggle="yes">Acinetobacter baumannii</italic> by formation of a factor I-dependent quadripartite assemblage</article-title><source>Front Immunol</source><year>2022</year><pub-id pub-id-type="doi">10.3389/fimmu.2022.942482</pub-id><pub-id pub-id-type="pmid">35958553</pub-id><pub-id pub-id-type="pmcid">PMC9361855</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Ries JI, He&#223; M, Nouri N, Wichelhaus TA, G&#246;ttig S, Falcone FH et al (2022) <italic toggle="yes">CipA</italic> mediates complement resistance of <italic toggle="yes">Acinetobacter baumannii</italic> by formation of a factor I-dependent quadripartite assemblage. Front Immunol. 10.3389/fimmu.2022.942482<pub-id pub-id-type="pmid">35958553</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2022.942482</pub-id><pub-id pub-id-type="pmcid">PMC9361855</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Russo</surname><given-names>TA</given-names></name><name name-style="western"><surname>Luke</surname><given-names>NR</given-names></name><name name-style="western"><surname>Beanan</surname><given-names>JM</given-names></name><name name-style="western"><surname>Olson</surname><given-names>R</given-names></name><name name-style="western"><surname>Sauberan</surname><given-names>SL</given-names></name><name name-style="western"><surname>MacDonald</surname><given-names>U</given-names></name><etal/></person-group><article-title>The K1 capsular polysaccharide of <italic toggle="yes">Acinetobacter baumannii</italic> strain 307&#8211;0294 is a major virulence factor</article-title><source>Infect Immun</source><year>2010</year><volume>78</volume><fpage>3993</fpage><lpage>4000</lpage><pub-id pub-id-type="doi">10.1128/IAI.00366-10</pub-id><pub-id pub-id-type="pmid">20643860</pub-id><pub-id pub-id-type="pmcid">PMC2937447</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Russo TA, Luke NR, Beanan JM, Olson R, Sauberan SL, MacDonald U et al (2010) The K1 capsular polysaccharide of <italic toggle="yes">Acinetobacter baumannii</italic> strain 307&#8211;0294 is a major virulence factor. Infect Immun 78:3993&#8211;4000. 10.1128/IAI.00366-10<pub-id pub-id-type="pmid">20643860</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.00366-10</pub-id><pub-id pub-id-type="pmcid">PMC2937447</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luke</surname><given-names>NR</given-names></name><name name-style="western"><surname>Sauberan</surname><given-names>SL</given-names></name><name name-style="western"><surname>Russo</surname><given-names>TA</given-names></name><name name-style="western"><surname>Beanan</surname><given-names>JM</given-names></name><name name-style="western"><surname>Olson</surname><given-names>R</given-names></name><name name-style="western"><surname>Loehfelm</surname><given-names>TW</given-names></name><etal/></person-group><article-title>Identification and characterization of a glycosyltransferase involved in <italic toggle="yes">Acinetobacter baumannii</italic> lipopolysaccharide core biosynthesis</article-title><source>Infect Immun</source><year>2010</year><volume>78</volume><fpage>2017</fpage><lpage>2023</lpage><pub-id pub-id-type="doi">10.1128/IAI.00016-10</pub-id><pub-id pub-id-type="pmid">20194587</pub-id><pub-id pub-id-type="pmcid">PMC2863528</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Luke NR, Sauberan SL, Russo TA, Beanan JM, Olson R, Loehfelm TW et al (2010) Identification and characterization of a glycosyltransferase involved in <italic toggle="yes">Acinetobacter baumannii</italic> lipopolysaccharide core biosynthesis. Infect Immun 78:2017&#8211;2023. 10.1128/IAI.00016-10<pub-id pub-id-type="pmid">20194587</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.00016-10</pub-id><pub-id pub-id-type="pmcid">PMC2863528</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lees-Miller</surname><given-names>RG</given-names></name><name name-style="western"><surname>Iwashkiw</surname><given-names>JA</given-names></name><name name-style="western"><surname>Scott</surname><given-names>NE</given-names></name><name name-style="western"><surname>Seper</surname><given-names>A</given-names></name><name name-style="western"><surname>Vinogradov</surname><given-names>E</given-names></name><name name-style="western"><surname>Schild</surname><given-names>S</given-names></name><etal/></person-group><article-title>A common pathway for <italic toggle="yes">O</italic>-linked protein-glycosylation and synthesis of capsule in <italic toggle="yes">Acinetobacter baumannii</italic></article-title><source>Mol Microbiol</source><year>2013</year><volume>89</volume><fpage>816</fpage><lpage>830</lpage><pub-id pub-id-type="doi">10.1111/mmi.12300</pub-id><pub-id pub-id-type="pmid">23782391</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Lees-Miller RG, Iwashkiw JA, Scott NE, Seper A, Vinogradov E, Schild S et al (2013) A common pathway for <italic toggle="yes">O</italic>-linked protein-glycosylation and synthesis of capsule in <italic toggle="yes">Acinetobacter baumannii</italic>. Mol Microbiol 89:816&#8211;830. 10.1111/mmi.12300<pub-id pub-id-type="pmid">23782391</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/mmi.12300</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamuyu</surname><given-names>G</given-names></name><name name-style="western"><surname>Ercoli</surname><given-names>G</given-names></name><name name-style="western"><surname>Ramos-Sevillano</surname><given-names>E</given-names></name><name name-style="western"><surname>Willcocks</surname><given-names>S</given-names></name><name name-style="western"><surname>Kewcharoenwong</surname><given-names>C</given-names></name><name name-style="western"><surname>Kiratisin</surname><given-names>P</given-names></name><etal/></person-group><article-title>Strain specific variations in <italic toggle="yes">Acinetobacter baumannii</italic> complement sensitivity</article-title><source>Front Immunol</source><year>2022</year><pub-id pub-id-type="doi">10.3389/fimmu.2022.853690</pub-id><pub-id pub-id-type="pmid">35812377</pub-id><pub-id pub-id-type="pmcid">PMC9258041</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Kamuyu G, Ercoli G, Ramos-Sevillano E, Willcocks S, Kewcharoenwong C, Kiratisin P et al (2022) Strain specific variations in <italic toggle="yes">Acinetobacter baumannii</italic> complement sensitivity. Front Immunol. 10.3389/fimmu.2022.853690<pub-id pub-id-type="pmid">35812377</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2022.853690</pub-id><pub-id pub-id-type="pmcid">PMC9258041</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mi&#281;dzybrodzki</surname><given-names>R</given-names></name><name name-style="western"><surname>Borysowski</surname><given-names>J</given-names></name><name name-style="western"><surname>Weber-D&#261;browska</surname><given-names>B</given-names></name><name name-style="western"><surname>Fortuna</surname><given-names>W</given-names></name><name name-style="western"><surname>Letkiewicz</surname><given-names>S</given-names></name><name name-style="western"><surname>Szufnarowski</surname><given-names>K</given-names></name><etal/></person-group><article-title>Clinical aspects of phage therapy</article-title><source>Adv Virus Res</source><year>2012</year><volume>83</volume><fpage>73</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-394438-2.00003-7</pub-id><pub-id pub-id-type="pmid">22748809</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Mi&#281;dzybrodzki R, Borysowski J, Weber-D&#261;browska B, Fortuna W, Letkiewicz S, Szufnarowski K et al (2012) Clinical aspects of phage therapy. Adv Virus Res 83:73&#8211;121. 10.1016/B978-0-12-394438-2.00003-7<pub-id pub-id-type="pmid">22748809</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/B978-0-12-394438-2.00003-7</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abedon</surname><given-names>ST</given-names></name><name name-style="western"><surname>Kuhl</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Blasdel</surname><given-names>BG</given-names></name><name name-style="western"><surname>Kutter</surname><given-names>EM</given-names></name></person-group><article-title>Phage treatment of human infections</article-title><source>Bacteriophage</source><year>2011</year><volume>1</volume><fpage>66</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.4161/bact.1.2.15845</pub-id><pub-id pub-id-type="pmid">22334863</pub-id><pub-id pub-id-type="pmcid">PMC3278644</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM (2011) Phage treatment of human infections. Bacteriophage 1:66&#8211;85. 10.4161/bact.1.2.15845<pub-id pub-id-type="pmid">22334863</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4161/bact.1.2.15845</pub-id><pub-id pub-id-type="pmcid">PMC3278644</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Slopek</surname><given-names>S</given-names></name><name name-style="western"><surname>Kucharewicz-Krukowska</surname><given-names>A</given-names></name><name name-style="western"><surname>Weber-Dabrowska</surname><given-names>B</given-names></name><name name-style="western"><surname>Dabrowski</surname><given-names>M</given-names></name></person-group><article-title>Results of bacteriophage treatment of suppurative bacterial infections. VI. Analysis of treatment of suppurative staphylococcal infections</article-title><source>Arch Immunol Ther Exp (Warsz)</source><year>1985</year><volume>33</volume><fpage>261</fpage><lpage>273</lpage><pub-id pub-id-type="pmid">2935117</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Slopek S, Kucharewicz-Krukowska A, Weber-Dabrowska B, Dabrowski M (1985) Results of bacteriophage treatment of suppurative bacterial infections. VI. Analysis of treatment of suppurative staphylococcal infections. Arch Immunol Ther Exp (Warsz) 33:261&#8211;273<pub-id pub-id-type="pmid">2935117</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Correa</surname><given-names>AMS</given-names></name><name name-style="western"><surname>Howard-Varona</surname><given-names>C</given-names></name><name name-style="western"><surname>Coy</surname><given-names>SR</given-names></name><name name-style="western"><surname>Buchan</surname><given-names>A</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>MB</given-names></name><name name-style="western"><surname>Weitz</surname><given-names>JS</given-names></name></person-group><article-title>Revisiting the rules of life for viruses of microorganisms</article-title><source>Nat Rev Microbiol</source><year>2021</year><volume>19</volume><fpage>501</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1038/s41579-021-00530-x</pub-id><pub-id pub-id-type="pmid">33762712</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Correa AMS, Howard-Varona C, Coy SR, Buchan A, Sullivan MB, Weitz JS (2021) Revisiting the rules of life for viruses of microorganisms. Nat Rev Microbiol 19:501&#8211;513. 10.1038/s41579-021-00530-x<pub-id pub-id-type="pmid">33762712</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41579-021-00530-x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hampton</surname><given-names>HG</given-names></name><name name-style="western"><surname>Watson</surname><given-names>BNJ</given-names></name><name name-style="western"><surname>Fineran</surname><given-names>PC</given-names></name></person-group><article-title>The arms race between bacteria and their phage foes</article-title><source>Nature</source><year>2020</year><volume>577</volume><fpage>327</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1894-8</pub-id><pub-id pub-id-type="pmid">31942051</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Hampton HG, Watson BNJ, Fineran PC (2020) The arms race between bacteria and their phage foes. Nature 577:327&#8211;336. 10.1038/s41586-019-1894-8<pub-id pub-id-type="pmid">31942051</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-019-1894-8</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Piel</surname><given-names>D</given-names></name><name name-style="western"><surname>Bruto</surname><given-names>M</given-names></name><name name-style="western"><surname>Labreuche</surname><given-names>Y</given-names></name><name name-style="western"><surname>Blanquart</surname><given-names>F</given-names></name><name name-style="western"><surname>Gouden&#232;ge</surname><given-names>D</given-names></name><name name-style="western"><surname>Barcia-Cruz</surname><given-names>R</given-names></name><etal/></person-group><article-title>Phage&#8211;host coevolution in natural populations</article-title><source>Nat Microbiol</source><year>2022</year><volume>7</volume><fpage>1075</fpage><lpage>1086</lpage><pub-id pub-id-type="doi">10.1038/s41564-022-01157-1</pub-id><pub-id pub-id-type="pmid">35760840</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Piel D, Bruto M, Labreuche Y, Blanquart F, Gouden&#232;ge D, Barcia-Cruz R et al (2022) Phage&#8211;host coevolution in natural populations. Nat Microbiol 7:1075&#8211;1086. 10.1038/s41564-022-01157-1<pub-id pub-id-type="pmid">35760840</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41564-022-01157-1</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ka&#378;mierczak</surname><given-names>Z</given-names></name><name name-style="western"><surname>Majewska</surname><given-names>J</given-names></name><name name-style="western"><surname>Miernikiewicz</surname><given-names>P</given-names></name><name name-style="western"><surname>Mi&#281;dzybrodzki</surname><given-names>R</given-names></name><name name-style="western"><surname>Nowak</surname><given-names>S</given-names></name><name name-style="western"><surname>Harhala</surname><given-names>M</given-names></name><etal/></person-group><article-title>Immune response to therapeutic <italic toggle="yes">staphylococcal</italic> bacteriophages in mammals: kinetics of induction, immunogenic structural proteins, natural and induced antibodies</article-title><source>Front Immunol</source><year>2021</year><pub-id pub-id-type="doi">10.3389/fimmu.2021.639570</pub-id><pub-id pub-id-type="pmid">34194425</pub-id><pub-id pub-id-type="pmcid">PMC8236893</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Ka&#378;mierczak Z, Majewska J, Miernikiewicz P, Mi&#281;dzybrodzki R, Nowak S, Harhala M et al (2021) Immune response to therapeutic <italic toggle="yes">staphylococcal</italic> bacteriophages in mammals: kinetics of induction, immunogenic structural proteins, natural and induced antibodies. Front Immunol. 10.3389/fimmu.2021.639570<pub-id pub-id-type="pmid">34194425</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2021.639570</pub-id><pub-id pub-id-type="pmcid">PMC8236893</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hodyra-Stefaniak</surname><given-names>K</given-names></name><name name-style="western"><surname>Miernikiewicz</surname><given-names>P</given-names></name><name name-style="western"><surname>Drapa&#322;a</surname><given-names>J</given-names></name><name name-style="western"><surname>Drab</surname><given-names>M</given-names></name><name name-style="western"><surname>Jo&#324;czyk-Matysiak</surname><given-names>E</given-names></name><name name-style="western"><surname>Lecion</surname><given-names>D</given-names></name><etal/></person-group><article-title>Mammalian host-versus-phage immune response determines phage fate <italic toggle="yes">in vivo</italic></article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><fpage>14802</fpage><pub-id pub-id-type="doi">10.1038/srep14802</pub-id><pub-id pub-id-type="pmid">26440922</pub-id><pub-id pub-id-type="pmcid">PMC4594097</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Hodyra-Stefaniak K, Miernikiewicz P, Drapa&#322;a J, Drab M, Jo&#324;czyk-Matysiak E, Lecion D et al (2015) Mammalian host-versus-phage immune response determines phage fate <italic toggle="yes">in vivo</italic>. Sci Rep 5:14802. 10.1038/srep14802<pub-id pub-id-type="pmid">26440922</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep14802</pub-id><pub-id pub-id-type="pmcid">PMC4594097</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ka&#378;mierczak</surname><given-names>Z</given-names></name><name name-style="western"><surname>Piotrowicz</surname><given-names>A</given-names></name><name name-style="western"><surname>Owczarek</surname><given-names>B</given-names></name><name name-style="western"><surname>Hodyra</surname><given-names>K</given-names></name><name name-style="western"><surname>Miernikiewicz</surname><given-names>P</given-names></name><name name-style="western"><surname>Lecion</surname><given-names>D</given-names></name><etal/></person-group><article-title>Molecular imaging of T4 phage in mammalian tissues and cells</article-title><source>Bacteriophage</source><year>2014</year><volume>4</volume><fpage>e28364</fpage><pub-id pub-id-type="doi">10.4161/bact.28364</pub-id><pub-id pub-id-type="pmid">24653943</pub-id><pub-id pub-id-type="pmcid">PMC3956486</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Ka&#378;mierczak Z, Piotrowicz A, Owczarek B, Hodyra K, Miernikiewicz P, Lecion D et al (2014) Molecular imaging of T4 phage in mammalian tissues and cells. Bacteriophage 4:e28364. 10.4161/bact.28364<pub-id pub-id-type="pmid">24653943</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4161/bact.28364</pub-id><pub-id pub-id-type="pmcid">PMC3956486</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Egido</surname><given-names>JE</given-names></name><name name-style="western"><surname>Dekker</surname><given-names>SO</given-names></name><name name-style="western"><surname>Toner-Bartelds</surname><given-names>C</given-names></name><name name-style="western"><surname>Lood</surname><given-names>C</given-names></name><name name-style="western"><surname>Rooijakkers</surname><given-names>SHM</given-names></name><name name-style="western"><surname>Bardoel</surname><given-names>BW</given-names></name><etal/></person-group><article-title>Human complement inhibits myophages against <italic toggle="yes">Pseudomonas aeruginosa</italic></article-title><source>Viruses</source><year>2023</year><volume>15</volume><fpage>2211</fpage><pub-id pub-id-type="doi">10.3390/v15112211</pub-id><pub-id pub-id-type="pmid">38005888</pub-id><pub-id pub-id-type="pmcid">PMC10674969</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Egido JE, Dekker SO, Toner-Bartelds C, Lood C, Rooijakkers SHM, Bardoel BW et al (2023) Human complement inhibits myophages against <italic toggle="yes">Pseudomonas aeruginosa</italic>. Viruses 15:2211. 10.3390/v15112211<pub-id pub-id-type="pmid">38005888</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/v15112211</pub-id><pub-id pub-id-type="pmcid">PMC10674969</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bodner</surname><given-names>K</given-names></name><name name-style="western"><surname>Melkonian</surname><given-names>AL</given-names></name><name name-style="western"><surname>Barth</surname><given-names>AIM</given-names></name><name name-style="western"><surname>Kudo</surname><given-names>T</given-names></name><name name-style="western"><surname>Tanouchi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Covert</surname><given-names>MW</given-names></name></person-group><article-title>Engineered fluorescent <italic toggle="yes">E</italic>. <italic toggle="yes">coli</italic> lysogens allow live-cell imaging of functional prophage induction triggered inside macrophages</article-title><source>Cell Syst</source><year>2020</year><volume>10</volume><fpage>254</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2020.02.006</pub-id><pub-id pub-id-type="pmid">32191875</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Bodner K, Melkonian AL, Barth AIM, Kudo T, Tanouchi Y, Covert MW (2020) Engineered fluorescent <italic toggle="yes">E</italic>. <italic toggle="yes">coli</italic> lysogens allow live-cell imaging of functional prophage induction triggered inside macrophages. Cell Syst 10:254&#8211;264. 10.1016/j.cels.2020.02.006<pub-id pub-id-type="pmid">32191875</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cels.2020.02.006</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abd El-Aziz</surname><given-names>AM</given-names></name><name name-style="western"><surname>Elgaml</surname><given-names>A</given-names></name><name name-style="western"><surname>Ali</surname><given-names>YM</given-names></name></person-group><article-title>Bacteriophage therapy increases complement-mediated lysis of bacteria and enhances bacterial clearance after acute lung infection with multidrug-resistant <italic toggle="yes">Pseudomonas aeruginosa</italic></article-title><source>J Infect Dis</source><year>2019</year><volume>219</volume><fpage>1439</fpage><lpage>1447</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiy678</pub-id><pub-id pub-id-type="pmid">30476337</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Abd El-Aziz AM, Elgaml A, Ali YM (2019) Bacteriophage therapy increases complement-mediated lysis of bacteria and enhances bacterial clearance after acute lung infection with multidrug-resistant <italic toggle="yes">Pseudomonas aeruginosa</italic>. J Infect Dis 219:1439&#8211;1447. 10.1093/infdis/jiy678<pub-id pub-id-type="pmid">30476337</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/jiy678</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kolsi</surname><given-names>A</given-names></name><name name-style="western"><surname>Haukka</surname><given-names>K</given-names></name><name name-style="western"><surname>Dougnon</surname><given-names>V</given-names></name><name name-style="western"><surname>Agbankp&#232;</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Fabiyi</surname><given-names>K</given-names></name><name name-style="western"><surname>Virta</surname><given-names>M</given-names></name><etal/></person-group><article-title>Isolation and characterization of three novel <italic toggle="yes">Acinetobacter baumannii</italic> phages from Beninese hospital wastewater</article-title><source>Arch Virol</source><year>2023</year><volume>168</volume><fpage>228</fpage><pub-id pub-id-type="doi">10.1007/s00705-023-05845-z</pub-id><pub-id pub-id-type="pmid">37574509</pub-id><pub-id pub-id-type="pmcid">PMC10423700</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Kolsi A, Haukka K, Dougnon V, Agbankp&#232; AJ, Fabiyi K, Virta M et al (2023) Isolation and characterization of three novel <italic toggle="yes">Acinetobacter baumannii</italic> phages from Beninese hospital wastewater. Arch Virol 168:228. 10.1007/s00705-023-05845-z<pub-id pub-id-type="pmid">37574509</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00705-023-05845-z</pub-id><pub-id pub-id-type="pmcid">PMC10423700</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="other">Sambrook J, Fritsch EF, Maniatis T (2001) Molecular cloning: a laboratory manual (3rd edn) Society. Cold Spring Harbor Laboratory, Cold Spring Harbor. 10.1128/AEM.68.3.1232</mixed-citation></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patpatia</surname><given-names>S</given-names></name><name name-style="western"><surname>Schaedig</surname><given-names>E</given-names></name><name name-style="western"><surname>Dirks</surname><given-names>A</given-names></name><name name-style="western"><surname>Paasonen</surname><given-names>L</given-names></name><name name-style="western"><surname>Skurnik</surname><given-names>M</given-names></name><name name-style="western"><surname>Kiljunen</surname><given-names>S</given-names></name></person-group><article-title>Rapid hydrogel-based phage susceptibility test for pathogenic bacteria</article-title><source>Front Cell Infect Microbiol</source><year>2022</year><pub-id pub-id-type="doi">10.3389/fcimb.2022.1032052</pub-id><pub-id pub-id-type="pmid">36569196</pub-id><pub-id pub-id-type="pmcid">PMC9771388</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Patpatia S, Schaedig E, Dirks A, Paasonen L, Skurnik M, Kiljunen S (2022) Rapid hydrogel-based phage susceptibility test for pathogenic bacteria. Front Cell Infect Microbiol. 10.3389/fcimb.2022.1032052<pub-id pub-id-type="pmid">36569196</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcimb.2022.1032052</pub-id><pub-id pub-id-type="pmcid">PMC9771388</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Domenico</surname><given-names>P</given-names></name><name name-style="western"><surname>Diedrich</surname><given-names>DL</given-names></name><name name-style="western"><surname>Cunha</surname><given-names>BA</given-names></name></person-group><article-title>Quantitative extraction and purification of exopolysaccharides from <italic toggle="yes">Klebsiella pneumoniae</italic></article-title><source>J Microbiol Methods</source><year>1989</year><volume>9</volume><fpage>211</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1016/0167-7012(89)90038-9</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Domenico P, Diedrich DL, Cunha BA (1989) Quantitative extraction and purification of exopolysaccharides from <italic toggle="yes">Klebsiella pneumoniae</italic>. J Microbiol Methods 9:211&#8211;219. 10.1016/0167-7012(89)90038-9</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galanos</surname><given-names>C</given-names></name><name name-style="western"><surname>L&#252;deritz</surname><given-names>O</given-names></name><name name-style="western"><surname>Westphal</surname><given-names>O</given-names></name></person-group><article-title>A new method for the extraction of R lipopolysaccharides</article-title><source>Eur J Biochem</source><year>1969</year><volume>9</volume><fpage>245</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1111/j.1432-1033.1969.tb00601.x</pub-id><pub-id pub-id-type="pmid">5804498</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Galanos C, L&#252;deritz O, Westphal O (1969) A new method for the extraction of R lipopolysaccharides. Eur J Biochem 9:245&#8211;249. 10.1111/j.1432-1033.1969.tb00601.x<pub-id pub-id-type="pmid">5804498</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1432-1033.1969.tb00601.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsai</surname><given-names>C-M</given-names></name><name name-style="western"><surname>Frasch</surname><given-names>CE</given-names></name></person-group><article-title>A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels</article-title><source>Anal Biochem</source><year>1982</year><volume>119</volume><fpage>115</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/0003-2697(82)90673-X</pub-id><pub-id pub-id-type="pmid">6176137</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Tsai C-M, Frasch CE (1982) A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem 119:115&#8211;119. 10.1016/0003-2697(82)90673-X<pub-id pub-id-type="pmid">6176137</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0003-2697(82)90673-x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fomsgaard</surname><given-names>A</given-names></name><name name-style="western"><surname>Freudenberg</surname><given-names>MA</given-names></name><name name-style="western"><surname>Galanos</surname><given-names>C</given-names></name></person-group><article-title>Modification of the silver staining technique to detect lipopolysaccharide in polyacrylamide gels</article-title><source>J Clin Microbiol</source><year>1990</year><volume>28</volume><fpage>2627</fpage><lpage>2631</lpage><pub-id pub-id-type="doi">10.1128/jcm.28.12.2627-2631.1990</pub-id><pub-id pub-id-type="pmid">1704012</pub-id><pub-id pub-id-type="pmcid">PMC268246</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Fomsgaard A, Freudenberg MA, Galanos C (1990) Modification of the silver staining technique to detect lipopolysaccharide in polyacrylamide gels. J Clin Microbiol 28:2627&#8211;2631. 10.1128/jcm.28.12.2627-2631.1990<pub-id pub-id-type="pmid">1704012</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/jcm.28.12.2627-2631.1990</pub-id><pub-id pub-id-type="pmcid">PMC268246</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dudek</surname><given-names>B</given-names></name><name name-style="western"><surname>Krzy&#380;ewska</surname><given-names>E</given-names></name><name name-style="western"><surname>Kapczy&#324;ska</surname><given-names>K</given-names></name><name name-style="western"><surname>Rybka</surname><given-names>J</given-names></name><name name-style="western"><surname>Pawlak</surname><given-names>A</given-names></name><name name-style="western"><surname>Korzekwa</surname><given-names>K</given-names></name><etal/></person-group><article-title>Proteomic analysis of outer membrane proteins from <italic toggle="yes">Salmonella enteritidis</italic> strains with different sensitivity to human serum</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><fpage>e0164069</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0164069</pub-id><pub-id pub-id-type="pmid">27695090</pub-id><pub-id pub-id-type="pmcid">PMC5047454</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Dudek B, Krzy&#380;ewska E, Kapczy&#324;ska K, Rybka J, Pawlak A, Korzekwa K et al (2016) Proteomic analysis of outer membrane proteins from <italic toggle="yes">Salmonella enteritidis</italic> strains with different sensitivity to human serum. PLoS ONE 11:e0164069. 10.1371/journal.pone.0164069<pub-id pub-id-type="pmid">27695090</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0164069</pub-id><pub-id pub-id-type="pmcid">PMC5047454</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coil</surname><given-names>D</given-names></name><name name-style="western"><surname>Jospin</surname><given-names>G</given-names></name><name name-style="western"><surname>Darling</surname><given-names>AE</given-names></name></person-group><article-title>A5-miseq: an updated pipeline to assemble microbial genomes from Illumina MiSeq data</article-title><source>Bioinformatics</source><year>2015</year><volume>31</volume><fpage>587</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu661</pub-id><pub-id pub-id-type="pmid">25338718</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Coil D, Jospin G, Darling AE (2015) A5-miseq: an updated pipeline to assemble microbial genomes from Illumina MiSeq data. Bioinformatics 31:587&#8211;589. 10.1093/bioinformatics/btu661<pub-id pub-id-type="pmid">25338718</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bioinformatics/btu661</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wick</surname><given-names>RR</given-names></name><name name-style="western"><surname>Judd</surname><given-names>LM</given-names></name><name name-style="western"><surname>Gorrie</surname><given-names>CL</given-names></name><name name-style="western"><surname>Holt</surname><given-names>KE</given-names></name></person-group><article-title>Unicycler: resolving bacterial genome assemblies from short and long sequencing reads</article-title><source>PLoS Comput Biol</source><year>2017</year><volume>13</volume><fpage>e1005595</fpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1005595</pub-id><pub-id pub-id-type="pmid">28594827</pub-id><pub-id pub-id-type="pmcid">PMC5481147</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Wick RR, Judd LM, Gorrie CL, Holt KE (2017) Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol 13:e1005595. 10.1371/journal.pcbi.1005595<pub-id pub-id-type="pmid">28594827</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pcbi.1005595</pub-id><pub-id pub-id-type="pmcid">PMC5481147</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wattam</surname><given-names>AR</given-names></name><name name-style="western"><surname>Davis</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Assaf</surname><given-names>R</given-names></name><name name-style="western"><surname>Boisvert</surname><given-names>S</given-names></name><name name-style="western"><surname>Brettin</surname><given-names>T</given-names></name><name name-style="western"><surname>Bun</surname><given-names>C</given-names></name><etal/></person-group><article-title>Improvements to PATRIC, the all-bacterial bioinformatics database and analysis resource center</article-title><source>Nucleic Acids Res</source><year>2017</year><volume>45</volume><fpage>D535</fpage><lpage>D542</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw1017</pub-id><pub-id pub-id-type="pmid">27899627</pub-id><pub-id pub-id-type="pmcid">PMC5210524</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Wattam AR, Davis JJ, Assaf R, Boisvert S, Brettin T, Bun C et al (2017) Improvements to PATRIC, the all-bacterial bioinformatics database and analysis resource center. Nucleic Acids Res 45:D535&#8211;D542. 10.1093/nar/gkw1017<pub-id pub-id-type="pmid">27899627</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkw1017</pub-id><pub-id pub-id-type="pmcid">PMC5210524</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aziz</surname><given-names>RK</given-names></name><name name-style="western"><surname>Bartels</surname><given-names>D</given-names></name><name name-style="western"><surname>Best</surname><given-names>AA</given-names></name><name name-style="western"><surname>DeJongh</surname><given-names>M</given-names></name><name name-style="western"><surname>Disz</surname><given-names>T</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>RA</given-names></name><etal/></person-group><article-title>The RAST server: rapid annotations using subsystems technology</article-title><source>BMC Genom</source><year>2008</year><volume>9</volume><fpage>75</fpage><pub-id pub-id-type="doi">10.1186/1471-2164-9-75</pub-id><pub-id pub-id-type="pmcid">PMC2265698</pub-id><pub-id pub-id-type="pmid">18261238</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA et al (2008) The RAST server: rapid annotations using subsystems technology. BMC Genom 9:75. 10.1186/1471-2164-9-75<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1471-2164-9-75</pub-id><pub-id pub-id-type="pmcid">PMC2265698</pub-id><pub-id pub-id-type="pmid">18261238</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Overbeek</surname><given-names>R</given-names></name><name name-style="western"><surname>Olson</surname><given-names>R</given-names></name><name name-style="western"><surname>Pusch</surname><given-names>GD</given-names></name><name name-style="western"><surname>Olsen</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Davis</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Disz</surname><given-names>T</given-names></name><etal/></person-group><article-title>The SEED and the rapid annotation of microbial genomes using Subsystems Technology (RAST)</article-title><source>Nucleic Acids Res</source><year>2014</year><volume>42</volume><fpage>D206</fpage><lpage>D214</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt1226</pub-id><pub-id pub-id-type="pmid">24293654</pub-id><pub-id pub-id-type="pmcid">PMC3965101</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Overbeek R, Olson R, Pusch GD, Olsen GJ, Davis JJ, Disz T et al (2014) The SEED and the rapid annotation of microbial genomes using Subsystems Technology (RAST). Nucleic Acids Res 42:D206&#8211;D214. 10.1093/nar/gkt1226<pub-id pub-id-type="pmid">24293654</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkt1226</pub-id><pub-id pub-id-type="pmcid">PMC3965101</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brettin</surname><given-names>T</given-names></name><name name-style="western"><surname>Davis</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Disz</surname><given-names>T</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>RA</given-names></name><name name-style="western"><surname>Gerdes</surname><given-names>S</given-names></name><name name-style="western"><surname>Olsen</surname><given-names>GJ</given-names></name><etal/></person-group><article-title>RASTtk: a modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes</article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><fpage>8365</fpage><pub-id pub-id-type="doi">10.1038/srep08365</pub-id><pub-id pub-id-type="pmid">25666585</pub-id><pub-id pub-id-type="pmcid">PMC4322359</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Brettin T, Davis JJ, Disz T, Edwards RA, Gerdes S, Olsen GJ et al (2015) RASTtk: a modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes. Sci Rep 5:8365. 10.1038/srep08365<pub-id pub-id-type="pmid">25666585</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep08365</pub-id><pub-id pub-id-type="pmcid">PMC4322359</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wyres</surname><given-names>KL</given-names></name><name name-style="western"><surname>Cahill</surname><given-names>SM</given-names></name><name name-style="western"><surname>Holt</surname><given-names>KE</given-names></name><name name-style="western"><surname>Hall</surname><given-names>RM</given-names></name><name name-style="western"><surname>Kenyon</surname><given-names>JJ</given-names></name></person-group><article-title>Identification of <italic toggle="yes">Acinetobacter baumannii</italic> loci for capsular polysaccharide (KL) and lipooligosaccharide outer core (OCL) synthesis in genome assemblies using curated reference databases compatible with Kaptive</article-title><source>Microb Genom</source><year>2020</year><volume>6</volume><fpage>e000339</fpage><pub-id pub-id-type="doi">10.1099/mgen.0.000339</pub-id><pub-id pub-id-type="pmid">32118530</pub-id><pub-id pub-id-type="pmcid">PMC7200062</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Wyres KL, Cahill SM, Holt KE, Hall RM, Kenyon JJ (2020) Identification of <italic toggle="yes">Acinetobacter baumannii</italic> loci for capsular polysaccharide (KL) and lipooligosaccharide outer core (OCL) synthesis in genome assemblies using curated reference databases compatible with Kaptive. Microb Genom 6:e000339. 10.1099/mgen.0.000339<pub-id pub-id-type="pmid">32118530</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1099/mgen.0.000339</pub-id><pub-id pub-id-type="pmcid">PMC7200062</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cahill</surname><given-names>SM</given-names></name><name name-style="western"><surname>Hall</surname><given-names>RM</given-names></name><name name-style="western"><surname>Kenyon</surname><given-names>JJ</given-names></name></person-group><article-title>An update to the database for <italic toggle="yes">Acinetobacter baumannii</italic> capsular polysaccharide locus typing extends the extensive and diverse repertoire of genes found at and outside the K locus</article-title><source>Microb Genom</source><year>2022</year><volume>8</volume><fpage>000878</fpage><pub-id pub-id-type="doi">10.1099/mgen.0.000878</pub-id><pub-id pub-id-type="pmcid">PMC9676051</pub-id><pub-id pub-id-type="pmid">36214673</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Cahill SM, Hall RM, Kenyon JJ (2022) An update to the database for <italic toggle="yes">Acinetobacter baumannii</italic> capsular polysaccharide locus typing extends the extensive and diverse repertoire of genes found at and outside the K locus. Microb Genom 8:000878. 10.1099/mgen.0.000878<pub-id pub-id-type="doi" assigning-authority="pmc">10.1099/mgen.0.000878</pub-id><pub-id pub-id-type="pmcid">PMC9676051</pub-id><pub-id pub-id-type="pmid">36214673</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Altschul</surname><given-names>SF</given-names></name><name name-style="western"><surname>Gish</surname><given-names>W</given-names></name><name name-style="western"><surname>Miller</surname><given-names>W</given-names></name><name name-style="western"><surname>Myers</surname><given-names>EW</given-names></name><name name-style="western"><surname>Lipman</surname><given-names>DJ</given-names></name></person-group><article-title>Basic local alignment search tool</article-title><source>J Mol Biol</source><year>1990</year><volume>215</volume><fpage>403</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/S0022-2836(05)80360-2</pub-id><pub-id pub-id-type="pmid">2231712</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215:403&#8211;410. 10.1016/S0022-2836(05)80360-2<pub-id pub-id-type="pmid">2231712</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0022-2836(05)80360-2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siguier</surname><given-names>P</given-names></name></person-group><article-title>ISfinder: the reference centre for bacterial insertion sequences</article-title><source>Nucleic Acids Res</source><year>2006</year><volume>34</volume><fpage>D32</fpage><lpage>D36</lpage><pub-id pub-id-type="doi">10.1093/nar/gkj014</pub-id><pub-id pub-id-type="pmid">16381877</pub-id><pub-id pub-id-type="pmcid">PMC1347377</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Siguier P (2006) ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res 34:D32&#8211;D36. 10.1093/nar/gkj014<pub-id pub-id-type="pmid">16381877</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkj014</pub-id><pub-id pub-id-type="pmcid">PMC1347377</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kallio</surname><given-names>MA</given-names></name><name name-style="western"><surname>Tuimala</surname><given-names>JT</given-names></name><name name-style="western"><surname>Hupponen</surname><given-names>T</given-names></name><name name-style="western"><surname>Klemel&#228;</surname><given-names>P</given-names></name><name name-style="western"><surname>Gentile</surname><given-names>M</given-names></name><name name-style="western"><surname>Scheinin</surname><given-names>I</given-names></name><etal/></person-group><article-title>Chipster: user-friendly analysis software for microarray and other high-throughput data</article-title><source>BMC Genom</source><year>2011</year><volume>12</volume><fpage>507</fpage><pub-id pub-id-type="doi">10.1186/1471-2164-12-507</pub-id><pub-id pub-id-type="pmcid">PMC3215701</pub-id><pub-id pub-id-type="pmid">21999641</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Kallio MA, Tuimala JT, Hupponen T, Klemel&#228; P, Gentile M, Scheinin I et al (2011) Chipster: user-friendly analysis software for microarray and other high-throughput data. BMC Genom 12:507. 10.1186/1471-2164-12-507<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1471-2164-12-507</pub-id><pub-id pub-id-type="pmcid">PMC3215701</pub-id><pub-id pub-id-type="pmid">21999641</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Langmead</surname><given-names>B</given-names></name><name name-style="western"><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><article-title>Fast gapped-read alignment with bowtie 2</article-title><source>Nat Methods</source><year>2012</year><volume>9</volume><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id><pub-id pub-id-type="pmid">22388286</pub-id><pub-id pub-id-type="pmcid">PMC3322381</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Langmead B, Salzberg SL (2012) Fast gapped-read alignment with bowtie 2. Nat Methods 9:357&#8211;359. 10.1038/nmeth.1923<pub-id pub-id-type="pmid">22388286</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nmeth.1923</pub-id><pub-id pub-id-type="pmcid">PMC3322381</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiong</surname><given-names>L</given-names></name><name name-style="western"><surname>Yi</surname><given-names>F</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Q</given-names></name><name name-style="western"><surname>Huang</surname><given-names>X</given-names></name><name name-style="western"><surname>Ao</surname><given-names>K</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Transcriptomic analysis reveals the regulatory role of quorum sensing in the <italic toggle="yes">Acinetobacter baumannii</italic> ATCC 19606 via RNA-seq</article-title><source>BMC Microbiol</source><year>2022</year><volume>22</volume><fpage>198</fpage><pub-id pub-id-type="doi">10.1186/s12866-022-02612-z</pub-id><pub-id pub-id-type="pmid">35971084</pub-id><pub-id pub-id-type="pmcid">PMC9380347</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Xiong L, Yi F, Yu Q, Huang X, Ao K, Wang Y et al (2022) Transcriptomic analysis reveals the regulatory role of quorum sensing in the <italic toggle="yes">Acinetobacter baumannii</italic> ATCC 19606 via RNA-seq. BMC Microbiol 22:198. 10.1186/s12866-022-02612-z<pub-id pub-id-type="pmid">35971084</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12866-022-02612-z</pub-id><pub-id pub-id-type="pmcid">PMC9380347</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abueg</surname><given-names>LAL</given-names></name><name name-style="western"><surname>Afgan</surname><given-names>E</given-names></name><name name-style="western"><surname>Allart</surname><given-names>O</given-names></name><name name-style="western"><surname>Awan</surname><given-names>AH</given-names></name><name name-style="western"><surname>Bacon</surname><given-names>WA</given-names></name><name name-style="western"><surname>Baker</surname><given-names>D</given-names></name><etal/></person-group><article-title>The Galaxy platform for accessible, reproducible, and collaborative data analyses: 2024 update</article-title><source>Nucleic Acids Res</source><year>2024</year><volume>52</volume><fpage>W83</fpage><lpage>W94</lpage><pub-id pub-id-type="doi">10.1093/NAR/GKAE410</pub-id><pub-id pub-id-type="pmid">38769056</pub-id><pub-id pub-id-type="pmcid">PMC11223835</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Abueg LAL, Afgan E, Allart O, Awan AH, Bacon WA, Baker D et al (2024) The Galaxy platform for accessible, reproducible, and collaborative data analyses: 2024 update. Nucleic Acids Res 52:W83&#8211;W94. 10.1093/NAR/GKAE410<pub-id pub-id-type="pmid">38769056</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkae410</pub-id><pub-id pub-id-type="pmcid">PMC11223835</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vieira</surname><given-names>M</given-names></name><name name-style="western"><surname>Duarte</surname><given-names>J</given-names></name><name name-style="western"><surname>Domingues</surname><given-names>R</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>H</given-names></name><name name-style="western"><surname>Dias</surname><given-names>O</given-names></name></person-group><article-title>PhageDPO: phage depolymerase finder</article-title><source>BioRxiv</source><year>2023</year><pub-id pub-id-type="doi">10.1101/2023.02.24.529883</pub-id><pub-id pub-id-type="pmid">39951981</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Vieira M, Duarte J, Domingues R, Oliveira H, Dias O (2023) PhageDPO: phage depolymerase finder. BioRxiv. 10.1101/2023.02.24.52988338106154
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>G&#243;rski</surname><given-names>A</given-names></name><name name-style="western"><surname>Miedzybrodzki</surname><given-names>R</given-names></name><name name-style="western"><surname>Borysowski</surname><given-names>J</given-names></name><name name-style="western"><surname>Dabrowska</surname><given-names>K</given-names></name><name name-style="western"><surname>Wierzbicki</surname><given-names>P</given-names></name><name name-style="western"><surname>Ohams</surname><given-names>M</given-names></name><etal/></person-group><article-title>Phage as a modulator of immune responses: practical implications for phage therapy</article-title><source>Adv Virus Res</source><year>2012</year><volume>83</volume><fpage>41</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-394438-2.00002-5</pub-id><pub-id pub-id-type="pmid">22748808</pub-id></element-citation><mixed-citation id="mc-CR60" publication-type="journal">G&#243;rski A, Miedzybrodzki R, Borysowski J, Dabrowska K, Wierzbicki P, Ohams M et al (2012) Phage as a modulator of immune responses: practical implications for phage therapy. Adv Virus Res 83:41&#8211;71. 10.1016/B978-0-12-394438-2.00002-5<pub-id pub-id-type="pmid">22748808</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/B978-0-12-394438-2.00002-5</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKeage</surname><given-names>K</given-names></name></person-group><article-title>Ravulizumab: first global approval</article-title><source>Drugs</source><year>2019</year><volume>79</volume><fpage>347</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1007/s40265-019-01068-2</pub-id><pub-id pub-id-type="pmid">30767127</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">McKeage K (2019) Ravulizumab: first global approval. Drugs 79:347&#8211;352. 10.1007/s40265-019-01068-2<pub-id pub-id-type="pmid">30767127</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s40265-019-01068-2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balaban</surname><given-names>NQ</given-names></name><name name-style="western"><surname>Merrin</surname><given-names>J</given-names></name><name name-style="western"><surname>Chait</surname><given-names>R</given-names></name><name name-style="western"><surname>Kowalik</surname><given-names>L</given-names></name><name name-style="western"><surname>Leibler</surname><given-names>S</given-names></name></person-group><article-title>Bacterial persistence as a phenotypic switch</article-title><source>Science</source><year>1979</year><volume>2004</volume><issue>305</issue><fpage>1622</fpage><lpage>1625</lpage><pub-id pub-id-type="doi">10.1126/science.1099390</pub-id><pub-id pub-id-type="pmid">15308767</pub-id></element-citation><mixed-citation id="mc-CR62" publication-type="journal">Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S (1979) Bacterial persistence as a phenotypic switch. Science 2004(305):1622&#8211;1625. 10.1126/science.1099390<pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1099390</pub-id><pub-id pub-id-type="pmid">15308767</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Avery</surname><given-names>SV</given-names></name></person-group><article-title>Microbial cell individuality and the underlying sources of heterogeneity</article-title><source>Nat Rev Microbiol</source><year>2006</year><volume>4</volume><fpage>577</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1038/nrmicro1460</pub-id><pub-id pub-id-type="pmid">16845428</pub-id></element-citation><mixed-citation id="mc-CR63" publication-type="journal">Avery SV (2006) Microbial cell individuality and the underlying sources of heterogeneity. Nat Rev Microbiol 4:577&#8211;587. 10.1038/nrmicro1460<pub-id pub-id-type="pmid">16845428</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrmicro1460</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pires</surname><given-names>DP</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>H</given-names></name><name name-style="western"><surname>Melo</surname><given-names>LDR</given-names></name><name name-style="western"><surname>Sillankorva</surname><given-names>S</given-names></name><name name-style="western"><surname>Azeredo</surname><given-names>J</given-names></name></person-group><article-title>Bacteriophage-encoded depolymerases: their diversity and biotechnological applications</article-title><source>Appl Microbiol Biotechnol</source><year>2016</year><volume>100</volume><issue>5</issue><fpage>2141</fpage><lpage>2151</lpage><pub-id pub-id-type="doi">10.1007/S00253-015-7247-0</pub-id><pub-id pub-id-type="pmid">26767986</pub-id></element-citation><mixed-citation id="mc-CR64" publication-type="journal">Pires DP, Oliveira H, Melo LDR, Sillankorva S, Azeredo J (2016) Bacteriophage-encoded depolymerases: their diversity and biotechnological applications. Appl Microbiol Biotechnol 100(5):2141&#8211;2151. 10.1007/S00253-015-7247-0<pub-id pub-id-type="pmid">26767986</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00253-015-7247-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knecht</surname><given-names>LE</given-names></name><name name-style="western"><surname>Veljkovic</surname><given-names>M</given-names></name><name name-style="western"><surname>Fieseler</surname><given-names>L</given-names></name></person-group><article-title>Diversity and function of phage encoded depolymerases</article-title><source>Front Microbiol</source><year>2020</year><volume>10</volume><fpage>502215</fpage><pub-id pub-id-type="doi">10.3389/FMICB.2019.02949</pub-id><pub-id pub-id-type="pmcid">PMC6966330</pub-id><pub-id pub-id-type="pmid">31998258</pub-id></element-citation><mixed-citation id="mc-CR65" publication-type="journal">Knecht LE, Veljkovic M, Fieseler L (2020) Diversity and function of phage encoded depolymerases. Front Microbiol 10:502215. 10.3389/FMICB.2019.02949<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmicb.2019.02949</pub-id><pub-id pub-id-type="pmcid">PMC6966330</pub-id><pub-id pub-id-type="pmid">31998258</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>M</given-names></name><name name-style="western"><surname>Hernandez-Morales</surname><given-names>A</given-names></name><name name-style="western"><surname>Clark</surname><given-names>J</given-names></name><name name-style="western"><surname>Le</surname><given-names>T</given-names></name><name name-style="western"><surname>Biswas</surname><given-names>B</given-names></name><name name-style="western"><surname>Bishop-Lilly</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Comparative genomics of <italic toggle="yes">Acinetobacter baumannii</italic> and therapeutic bacteriophages from a patient undergoing phage therapy</article-title><source>Nat Commun</source><year>2022</year><volume>13</volume><fpage>3776</fpage><pub-id pub-id-type="doi">10.1038/s41467-022-31455-5</pub-id><pub-id pub-id-type="pmid">35773283</pub-id><pub-id pub-id-type="pmcid">PMC9247103</pub-id></element-citation><mixed-citation id="mc-CR66" publication-type="journal">Liu M, Hernandez-Morales A, Clark J, Le T, Biswas B, Bishop-Lilly KA et al (2022) Comparative genomics of <italic toggle="yes">Acinetobacter baumannii</italic> and therapeutic bacteriophages from a patient undergoing phage therapy. Nat Commun 13:3776. 10.1038/s41467-022-31455-5<pub-id pub-id-type="pmid">35773283</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-022-31455-5</pub-id><pub-id pub-id-type="pmcid">PMC9247103</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gordillo Altamirano</surname><given-names>F</given-names></name><name name-style="western"><surname>Forsyth</surname><given-names>JH</given-names></name><name name-style="western"><surname>Patwa</surname><given-names>R</given-names></name><name name-style="western"><surname>Kostoulias</surname><given-names>X</given-names></name><name name-style="western"><surname>Trim</surname><given-names>M</given-names></name><name name-style="western"><surname>Subedi</surname><given-names>D</given-names></name><etal/></person-group><article-title>Bacteriophage-resistant <italic toggle="yes">Acinetobacter baumannii</italic> are resensitized to antimicrobials</article-title><source>Nat Microbiol</source><year>2021</year><volume>6</volume><fpage>157</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1038/s41564-020-00830-7</pub-id><pub-id pub-id-type="pmid">33432151</pub-id></element-citation><mixed-citation id="mc-CR67" publication-type="journal">Gordillo Altamirano F, Forsyth JH, Patwa R, Kostoulias X, Trim M, Subedi D et al (2021) Bacteriophage-resistant <italic toggle="yes">Acinetobacter baumannii</italic> are resensitized to antimicrobials. Nat Microbiol 6:157&#8211;161. 10.1038/s41564-020-00830-7<pub-id pub-id-type="pmid">33432151</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41564-020-00830-7</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siguier</surname><given-names>P</given-names></name><name name-style="western"><surname>Gagnevin</surname><given-names>L</given-names></name><name name-style="western"><surname>Chandler</surname><given-names>M</given-names></name></person-group><article-title>The new IS1595 family, its relation to IS1 and the frontier between insertion sequences and transposons</article-title><source>Res Microbiol</source><year>2009</year><volume>160</volume><fpage>232</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1016/j.resmic.2009.02.003</pub-id><pub-id pub-id-type="pmid">19286454</pub-id></element-citation><mixed-citation id="mc-CR68" publication-type="journal">Siguier P, Gagnevin L, Chandler M (2009) The new IS1595 family, its relation to IS1 and the frontier between insertion sequences and transposons. Res Microbiol 160:232&#8211;241. 10.1016/j.resmic.2009.02.003<pub-id pub-id-type="pmid">19286454</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.resmic.2009.02.003</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hickman</surname><given-names>AB</given-names></name><name name-style="western"><surname>Dyda</surname><given-names>F</given-names></name></person-group><article-title>DNA transposition at work</article-title><source>Chem Rev</source><year>2016</year><volume>116</volume><fpage>12758</fpage><lpage>12784</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrev.6b00003</pub-id><pub-id pub-id-type="pmid">27187082</pub-id><pub-id pub-id-type="pmcid">PMC6380494</pub-id></element-citation><mixed-citation id="mc-CR69" publication-type="journal">Hickman AB, Dyda F (2016) DNA transposition at work. Chem Rev 116:12758&#8211;12784. 10.1021/acs.chemrev.6b00003<pub-id pub-id-type="pmid">27187082</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.chemrev.6b00003</pub-id><pub-id pub-id-type="pmcid">PMC6380494</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mu&#241;oz-L&#243;pez</surname><given-names>M</given-names></name><name name-style="western"><surname>Garc&#237;a-P&#233;rez</surname><given-names>JL</given-names></name></person-group><article-title>DNA transposons: nature and applications in genomics</article-title><source>Curr Genom</source><year>2010</year><volume>11</volume><fpage>115</fpage><pub-id pub-id-type="doi">10.2174/138920210790886871</pub-id><pub-id pub-id-type="pmcid">PMC2874221</pub-id><pub-id pub-id-type="pmid">20885819</pub-id></element-citation><mixed-citation id="mc-CR70" publication-type="journal">Mu&#241;oz-L&#243;pez M, Garc&#237;a-P&#233;rez JL (2010) DNA transposons: nature and applications in genomics. Curr Genom 11:115. 10.2174/138920210790886871<pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/138920210790886871</pub-id><pub-id pub-id-type="pmcid">PMC2874221</pub-id><pub-id pub-id-type="pmid">20885819</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gordillo Altamirano</surname><given-names>FL</given-names></name><name name-style="western"><surname>Kostoulias</surname><given-names>X</given-names></name><name name-style="western"><surname>Subedi</surname><given-names>D</given-names></name><name name-style="western"><surname>Korneev</surname><given-names>D</given-names></name><name name-style="western"><surname>Peleg</surname><given-names>AY</given-names></name><name name-style="western"><surname>Barr</surname><given-names>JJ</given-names></name></person-group><article-title>Phage-antibiotic combination is a superior treatment against <italic toggle="yes">Acinetobacter baumannii</italic> in a preclinical study</article-title><source>EBioMedicine</source><year>2022</year><volume>80</volume><fpage>104045</fpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2022.104045</pub-id><pub-id pub-id-type="pmid">35537278</pub-id><pub-id pub-id-type="pmcid">PMC9097682</pub-id></element-citation><mixed-citation id="mc-CR71" publication-type="journal">Gordillo Altamirano FL, Kostoulias X, Subedi D, Korneev D, Peleg AY, Barr JJ (2022) Phage-antibiotic combination is a superior treatment against <italic toggle="yes">Acinetobacter baumannii</italic> in a preclinical study. EBioMedicine 80:104045. 10.1016/j.ebiom.2022.104045<pub-id pub-id-type="pmid">35537278</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ebiom.2022.104045</pub-id><pub-id pub-id-type="pmcid">PMC9097682</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oleksiewicz</surname><given-names>MB</given-names></name><name name-style="western"><surname>Nagy</surname><given-names>G</given-names></name><name name-style="western"><surname>Nagy</surname><given-names>E</given-names></name></person-group><article-title>Anti-bacterial monoclonal antibodies: back to the future?</article-title><source>Arch Biochem Biophys</source><year>2012</year><volume>526</volume><fpage>124</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1016/J.ABB.2012.06.001</pub-id><pub-id pub-id-type="pmid">22705202</pub-id></element-citation><mixed-citation id="mc-CR72" publication-type="journal">Oleksiewicz MB, Nagy G, Nagy E (2012) Anti-bacterial monoclonal antibodies: back to the future? Arch Biochem Biophys 526:124&#8211;131. 10.1016/J.ABB.2012.06.001<pub-id pub-id-type="pmid">22705202</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.abb.2012.06.001</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xuan</surname><given-names>J</given-names></name><name name-style="western"><surname>Feng</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>R</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>B</given-names></name><name name-style="western"><surname>Bo</surname><given-names>L</given-names></name><etal/></person-group><article-title>Antimicrobial peptides for combating drug-resistant bacterial infections</article-title><source>Drug Resist Updat</source><year>2023</year><volume>68</volume><fpage>100954</fpage><pub-id pub-id-type="doi">10.1016/J.DRUP.2023.100954</pub-id><pub-id pub-id-type="pmid">36905712</pub-id></element-citation><mixed-citation id="mc-CR73" publication-type="journal">Xuan J, Feng W, Wang J, Wang R, Zhang B, Bo L et al (2023) Antimicrobial peptides for combating drug-resistant bacterial infections. Drug Resist Updat 68:100954. 10.1016/J.DRUP.2023.100954<pub-id pub-id-type="pmid">36905712</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drup.2023.100954</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seelen</surname><given-names>MA</given-names></name><name name-style="western"><surname>Roos</surname><given-names>A</given-names></name><name name-style="western"><surname>Wieslander</surname><given-names>J</given-names></name><name name-style="western"><surname>Mollnes</surname><given-names>TE</given-names></name><name name-style="western"><surname>Sj&#246;holm</surname><given-names>AG</given-names></name><name name-style="western"><surname>Wurzner</surname><given-names>R</given-names></name><etal/></person-group><article-title>Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA</article-title><source>J Immunol Methods</source><year>2005</year><volume>296</volume><fpage>187</fpage><lpage>198</lpage><pub-id pub-id-type="doi">10.1016/j.jim.2004.11.016</pub-id><pub-id pub-id-type="pmid">15680163</pub-id></element-citation><mixed-citation id="mc-CR74" publication-type="journal">Seelen MA, Roos A, Wieslander J, Mollnes TE, Sj&#246;holm AG, Wurzner R et al (2005) Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods 296:187&#8211;198. 10.1016/j.jim.2004.11.016<pub-id pub-id-type="pmid">15680163</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jim.2004.11.016</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roos</surname><given-names>A</given-names></name><name name-style="western"><surname>Bouwman</surname><given-names>LH</given-names></name><name name-style="western"><surname>Munoz</surname><given-names>J</given-names></name><name name-style="western"><surname>Zuiverloon</surname><given-names>T</given-names></name><name name-style="western"><surname>Faber-Krol</surname><given-names>MC</given-names></name><name name-style="western"><surname>van den Fallaux- Houten</surname><given-names>FC</given-names></name><etal/></person-group><article-title>Functional characterization of the lectin pathway of complement in human serum</article-title><source>Mol Immunol</source><year>2003</year><volume>39</volume><fpage>655</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1016/S0161-5890(02)00254-7</pub-id><pub-id pub-id-type="pmid">12493641</pub-id></element-citation><mixed-citation id="mc-CR75" publication-type="journal">Roos A, Bouwman LH, Munoz J, Zuiverloon T, Faber-Krol MC, van den Fallaux- Houten FC et al (2003) Functional characterization of the lectin pathway of complement in human serum. Mol Immunol 39:655&#8211;668. 10.1016/S0161-5890(02)00254-7<pub-id pub-id-type="pmid">12493641</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0161-5890(02)00254-7</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Loh</surname><given-names>B</given-names></name><name name-style="western"><surname>Gordillo Altamirano</surname><given-names>F</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hua</surname><given-names>X</given-names></name><name name-style="western"><surname>Leptihn</surname><given-names>S</given-names></name></person-group><article-title>Colistin-phage combinations decrease antibiotic resistance in <italic toggle="yes">Acinetobacter baumannii</italic> via changes in envelope architecture</article-title><source>Emerg Microbes Infect</source><year>2021</year><volume>10</volume><fpage>2205</fpage><lpage>2219</lpage><pub-id pub-id-type="doi">10.1080/22221751.2021.2002671</pub-id><pub-id pub-id-type="pmid">34736365</pub-id><pub-id pub-id-type="pmcid">PMC8648044</pub-id></element-citation><mixed-citation id="mc-CR76" publication-type="journal">Wang X, Loh B, Gordillo Altamirano F, Yu Y, Hua X, Leptihn S (2021) Colistin-phage combinations decrease antibiotic resistance in <italic toggle="yes">Acinetobacter baumannii</italic> via changes in envelope architecture. Emerg Microbes Infect 10:2205&#8211;2219. 10.1080/22221751.2021.2002671<pub-id pub-id-type="pmid">34736365</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/22221751.2021.2002671</pub-id><pub-id pub-id-type="pmcid">PMC8648044</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Winkelstein</surname><given-names>JA</given-names></name><name name-style="western"><surname>Bocchini</surname><given-names>JA</given-names></name><name name-style="western"><surname>Schiffman</surname><given-names>G</given-names></name></person-group><article-title>The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus</article-title><source>J Immunol</source><year>1976</year><volume>116</volume><fpage>367</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.4049/JIMMUNOL.116.2.367</pub-id><pub-id pub-id-type="pmid">2634</pub-id></element-citation><mixed-citation id="mc-CR77" publication-type="journal">Winkelstein JA, Bocchini JA, Schiffman G (1976) The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus. J Immunol 116:367&#8211;370. 10.4049/JIMMUNOL.116.2.367<pub-id pub-id-type="pmid">2634</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morrison</surname><given-names>DC</given-names></name><name name-style="western"><surname>Kline</surname><given-names>LF</given-names></name></person-group><article-title>Activation of the classical and Properdin pathways of complement by bacterial lipopolysaccharides (LPS)</article-title><source>J Immunol</source><year>1977</year><volume>118</volume><fpage>362</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.4049/JIMMUNOL.118.1.362</pub-id><pub-id pub-id-type="pmid">318670</pub-id></element-citation><mixed-citation id="mc-CR78" publication-type="journal">Morrison DC, Kline LF (1977) Activation of the classical and Properdin pathways of complement by bacterial lipopolysaccharides (LPS). J Immunol 118:362&#8211;368. 10.4049/JIMMUNOL.118.1.362<pub-id pub-id-type="pmid">318670</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gong</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qian</surname><given-names>X</given-names></name><name name-style="western"><surname>Xue</surname><given-names>F</given-names></name><etal/></person-group><article-title>Novel host recognition mechanism of the K1 capsule-specific phage of <italic toggle="yes">Escherichia coli</italic>: capsular polysaccharide as the first receptor and lipopolysaccharide as the secondary receptor</article-title><source>J Virol</source><year>2021</year><pub-id pub-id-type="doi">10.1128/JVI.00920-21</pub-id><pub-id pub-id-type="pmid">34191582</pub-id><pub-id pub-id-type="pmcid">PMC8387036</pub-id></element-citation><mixed-citation id="mc-CR79" publication-type="journal">Gong Q, Wang X, Huang H, Sun Y, Qian X, Xue F et al (2021) Novel host recognition mechanism of the K1 capsule-specific phage of <italic toggle="yes">Escherichia coli</italic>: capsular polysaccharide as the first receptor and lipopolysaccharide as the secondary receptor. J Virol. 10.1128/JVI.00920-21<pub-id pub-id-type="pmid">34191582</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JVI.00920-21</pub-id><pub-id pub-id-type="pmcid">PMC8387036</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grossman</surname><given-names>N</given-names></name><name name-style="western"><surname>Schmetz</surname><given-names>MA</given-names></name><name name-style="western"><surname>Foulds</surname><given-names>J</given-names></name><name name-style="western"><surname>Klima</surname><given-names>EN</given-names></name><name name-style="western"><surname>Jimenez-Lucho</surname><given-names>VE</given-names></name><name name-style="western"><surname>Leive</surname><given-names>LL</given-names></name><etal/></person-group><article-title>Lipopolysaccharide size and distribution determine serum resistance in <italic toggle="yes">Salmonella montevideo</italic></article-title><source>J Bacteriol</source><year>1987</year><volume>169</volume><fpage>856</fpage><lpage>863</lpage><pub-id pub-id-type="doi">10.1128/jb.169.2.856-863.1987</pub-id><pub-id pub-id-type="pmid">2433267</pub-id><pub-id pub-id-type="pmcid">PMC211858</pub-id></element-citation><mixed-citation id="mc-CR80" publication-type="journal">Grossman N, Schmetz MA, Foulds J, Klima EN, Jimenez-Lucho VE, Leive LL et al (1987) Lipopolysaccharide size and distribution determine serum resistance in <italic toggle="yes">Salmonella montevideo</italic>. J Bacteriol 169:856&#8211;863. 10.1128/jb.169.2.856-863.1987<pub-id pub-id-type="pmid">2433267</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/jb.169.2.856-863.1987</pub-id><pub-id pub-id-type="pmcid">PMC211858</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murray</surname><given-names>GL</given-names></name><name name-style="western"><surname>Attridge</surname><given-names>SR</given-names></name><name name-style="western"><surname>Morona</surname><given-names>R</given-names></name></person-group><article-title>Altering the length of the lipopolysaccharide O antigen has an impact on the interaction of <italic toggle="yes">Salmonella enterica</italic> serovar Typhimurium with macrophages and complement</article-title><source>J Bacteriol</source><year>2006</year><volume>188</volume><fpage>2735</fpage><lpage>2739</lpage><pub-id pub-id-type="doi">10.1128/JB.188.7.2735-2739.2006</pub-id><pub-id pub-id-type="pmid">16547065</pub-id><pub-id pub-id-type="pmcid">PMC1428429</pub-id></element-citation><mixed-citation id="mc-CR81" publication-type="journal">Murray GL, Attridge SR, Morona R (2006) Altering the length of the lipopolysaccharide O antigen has an impact on the interaction of <italic toggle="yes">Salmonella enterica</italic> serovar Typhimurium with macrophages and complement. J Bacteriol 188:2735&#8211;2739. 10.1128/JB.188.7.2735-2739.2006<pub-id pub-id-type="pmid">16547065</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JB.188.7.2735-2739.2006</pub-id><pub-id pub-id-type="pmcid">PMC1428429</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vishwanath</surname><given-names>S</given-names></name><name name-style="western"><surname>Hackstadt</surname><given-names>T</given-names></name></person-group><article-title>Lipopolysaccharide phase variation determines the complement-mediated serum susceptibility of <italic toggle="yes">Coxiella burnetii</italic></article-title><source>Infect Immun</source><year>1988</year><volume>56</volume><fpage>40</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1128/iai.56.1.40-44.1988</pub-id><pub-id pub-id-type="pmid">3335408</pub-id><pub-id pub-id-type="pmcid">PMC259230</pub-id></element-citation><mixed-citation id="mc-CR82" publication-type="journal">Vishwanath S, Hackstadt T (1988) Lipopolysaccharide phase variation determines the complement-mediated serum susceptibility of <italic toggle="yes">Coxiella burnetii</italic>. Infect Immun 56:40&#8211;44. 10.1128/iai.56.1.40-44.1988<pub-id pub-id-type="pmid">3335408</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.56.1.40-44.1988</pub-id><pub-id pub-id-type="pmcid">PMC259230</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tom&#225;s</surname><given-names>JM</given-names></name><name name-style="western"><surname>Bened&#237;</surname><given-names>VJ</given-names></name><name name-style="western"><surname>Ciurana</surname><given-names>B</given-names></name><name name-style="western"><surname>Jofre</surname><given-names>J</given-names></name></person-group><article-title>Role of capsule and O antigen in resistance of <italic toggle="yes">Klebsiella pneumoniae</italic> to serum bactericidal activity</article-title><source>Infect Immun</source><year>1986</year><volume>54</volume><fpage>85</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1128/iai.54.1.85-89.1986</pub-id><pub-id pub-id-type="pmid">3531020</pub-id><pub-id pub-id-type="pmcid">PMC260120</pub-id></element-citation><mixed-citation id="mc-CR83" publication-type="journal">Tom&#225;s JM, Bened&#237; VJ, Ciurana B, Jofre J (1986) Role of capsule and O antigen in resistance of <italic toggle="yes">Klebsiella pneumoniae</italic> to serum bactericidal activity. Infect Immun 54:85&#8211;89. 10.1128/iai.54.1.85-89.1986<pub-id pub-id-type="pmid">3531020</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.54.1.85-89.1986</pub-id><pub-id pub-id-type="pmcid">PMC260120</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olszak</surname><given-names>T</given-names></name><name name-style="western"><surname>Augustyniak</surname><given-names>D</given-names></name><name name-style="western"><surname>Garc&#237;a-Romero</surname><given-names>I</given-names></name><name name-style="western"><surname>Markwitz</surname><given-names>P</given-names></name><name name-style="western"><surname>Gula</surname><given-names>G</given-names></name><name name-style="western"><surname>Molinaro</surname><given-names>A</given-names></name><etal/></person-group><article-title>Phage treatment of <italic toggle="yes">Pseudomonas aeruginosa</italic> yields a phage-resistant population with different susceptibility to innate immune responses and mild effects on metabolic profiles</article-title><source>Microbiol Res</source><year>2024</year><volume>282</volume><fpage>127609</fpage><pub-id pub-id-type="doi">10.1016/j.micres.2024.127609</pub-id><pub-id pub-id-type="pmid">38428337</pub-id></element-citation><mixed-citation id="mc-CR84" publication-type="journal">Olszak T, Augustyniak D, Garc&#237;a-Romero I, Markwitz P, Gula G, Molinaro A et al (2024) Phage treatment of <italic toggle="yes">Pseudomonas aeruginosa</italic> yields a phage-resistant population with different susceptibility to innate immune responses and mild effects on metabolic profiles. Microbiol Res 282:127609. 10.1016/j.micres.2024.127609<pub-id pub-id-type="pmid">38428337</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.micres.2024.127609</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Mi</surname><given-names>Z</given-names></name><name name-style="western"><surname>Mi</surname><given-names>L</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>P</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Identification and characterization of capsule depolymerase Dpo48 from Acinetobacter baumannii phage IME200</article-title><source>PeerJ</source><year>2019</year><volume>2019</volume><fpage>e6173</fpage><pub-id pub-id-type="doi">10.7717/PEERJ.6173/SUPP-5</pub-id><pub-id pub-id-type="pmcid">PMC6336015</pub-id><pub-id pub-id-type="pmid">30656071</pub-id></element-citation><mixed-citation id="mc-CR85" publication-type="journal">Liu Y, Mi Z, Mi L, Huang Y, Li P, Liu H et al (2019) Identification and characterization of capsule depolymerase Dpo48 from Acinetobacter baumannii phage IME200. PeerJ 2019:e6173. 10.7717/PEERJ.6173/SUPP-5<pub-id pub-id-type="doi" assigning-authority="pmc">10.7717/peerj.6173</pub-id><pub-id pub-id-type="pmcid">PMC6336015</pub-id><pub-id pub-id-type="pmid">30656071</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abdelkader</surname><given-names>K</given-names></name><name name-style="western"><surname>Guti&#233;rrez</surname><given-names>D</given-names></name><name name-style="western"><surname>Latka</surname><given-names>A</given-names></name><name name-style="western"><surname>Boeckaerts</surname><given-names>D</given-names></name><name name-style="western"><surname>Drulis-Kawa</surname><given-names>Z</given-names></name><name name-style="western"><surname>Criel</surname><given-names>B</given-names></name><etal/></person-group><article-title>The specific capsule depolymerase of phage PMK34 sensitizes <italic toggle="yes">Acinetobacter baumannii</italic> to serum killing</article-title><source>Antibiotics</source><year>2022</year><volume>11</volume><fpage>677</fpage><pub-id pub-id-type="doi">10.3390/antibiotics11050677</pub-id><pub-id pub-id-type="pmid">35625321</pub-id><pub-id pub-id-type="pmcid">PMC9137491</pub-id></element-citation><mixed-citation id="mc-CR86" publication-type="journal">Abdelkader K, Guti&#233;rrez D, Latka A, Boeckaerts D, Drulis-Kawa Z, Criel B et al (2022) The specific capsule depolymerase of phage PMK34 sensitizes <italic toggle="yes">Acinetobacter baumannii</italic> to serum killing. Antibiotics 11:677. 10.3390/antibiotics11050677<pub-id pub-id-type="pmid">35625321</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/antibiotics11050677</pub-id><pub-id pub-id-type="pmcid">PMC9137491</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR87"><label>87.</label><citation-alternatives><element-citation id="ec-CR87" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P</given-names></name><name name-style="western"><surname>Xu</surname><given-names>M</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>W</given-names></name><name name-style="western"><surname>Bian</surname><given-names>L</given-names></name><etal/></person-group><article-title>Phage-derived depolymerase as an antibiotic adjuvant against multidrug-resistant <italic toggle="yes">Acinetobacter baumannii</italic></article-title><source>Front Microbiol</source><year>2022</year><pub-id pub-id-type="doi">10.3389/fmicb.2022.845500</pub-id><pub-id pub-id-type="pmid">35401491</pub-id><pub-id pub-id-type="pmcid">PMC8990738</pub-id></element-citation><mixed-citation id="mc-CR87" publication-type="journal">Chen X, Liu M, Zhang P, Xu M, Yuan W, Bian L et al (2022) Phage-derived depolymerase as an antibiotic adjuvant against multidrug-resistant <italic toggle="yes">Acinetobacter baumannii</italic>. Front Microbiol. 10.3389/fmicb.2022.845500<pub-id pub-id-type="pmid">35401491</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmicb.2022.845500</pub-id><pub-id pub-id-type="pmcid">PMC8990738</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR88"><label>88.</label><citation-alternatives><element-citation id="ec-CR88" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Geisinger</surname><given-names>E</given-names></name><name name-style="western"><surname>Isberg</surname><given-names>RR</given-names></name></person-group><article-title>Antibiotic modulation of capsular exopolysaccharide and virulence in <italic toggle="yes">Acinetobacter baumannii</italic></article-title><source>PLoS Pathog</source><year>2015</year><volume>11</volume><fpage>e1004691</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1004691</pub-id><pub-id pub-id-type="pmid">25679516</pub-id><pub-id pub-id-type="pmcid">PMC4334535</pub-id></element-citation><mixed-citation id="mc-CR88" publication-type="journal">Geisinger E, Isberg RR (2015) Antibiotic modulation of capsular exopolysaccharide and virulence in <italic toggle="yes">Acinetobacter baumannii</italic>. PLoS Pathog 11:e1004691. 10.1371/journal.ppat.1004691<pub-id pub-id-type="pmid">25679516</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.ppat.1004691</pub-id><pub-id pub-id-type="pmcid">PMC4334535</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR89"><label>89.</label><citation-alternatives><element-citation id="ec-CR89" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graham Solomons</surname><given-names>JT</given-names></name><name name-style="western"><surname>Zimmerly</surname><given-names>EM</given-names></name><name name-style="western"><surname>Burns</surname><given-names>S</given-names></name><name name-style="western"><surname>Krishnamurthy</surname><given-names>N</given-names></name><name name-style="western"><surname>Swan</surname><given-names>MK</given-names></name><name name-style="western"><surname>Krings</surname><given-names>S</given-names></name><etal/></person-group><article-title>The crystal structure of mouse phosphoglucose isomerase at 1.6&#197; resolution and its complex with glucose 6-phosphate reveals the catalytic mechanism of sugar ring opening</article-title><source>J Mol Biol</source><year>2004</year><volume>342</volume><fpage>847</fpage><lpage>860</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2004.07.085</pub-id><pub-id pub-id-type="pmid">15342241</pub-id></element-citation><mixed-citation id="mc-CR89" publication-type="journal">Graham Solomons JT, Zimmerly EM, Burns S, Krishnamurthy N, Swan MK, Krings S et al (2004) The crystal structure of mouse phosphoglucose isomerase at 1.6&#197; resolution and its complex with glucose 6-phosphate reveals the catalytic mechanism of sugar ring opening. J Mol Biol 342:847&#8211;860. 10.1016/j.jmb.2004.07.085<pub-id pub-id-type="pmid">15342241</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jmb.2004.07.085</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR90"><label>90.</label><citation-alternatives><element-citation id="ec-CR90" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bai</surname><given-names>J</given-names></name><name name-style="western"><surname>Raustad</surname><given-names>N</given-names></name><name name-style="western"><surname>Denoncourt</surname><given-names>J</given-names></name><name name-style="western"><surname>van Opijnen</surname><given-names>T</given-names></name><name name-style="western"><surname>Geisinger</surname><given-names>E</given-names></name></person-group><article-title>Genome-wide phage susceptibility analysis in <italic toggle="yes">Acinetobacter baumannii</italic> reveals capsule modulation strategies that determine phage infectivity</article-title><source>PLoS Pathog</source><year>2023</year><volume>19</volume><fpage>e1010928</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1010928</pub-id><pub-id pub-id-type="pmid">37289824</pub-id><pub-id pub-id-type="pmcid">PMC10249906</pub-id></element-citation><mixed-citation id="mc-CR90" publication-type="journal">Bai J, Raustad N, Denoncourt J, van Opijnen T, Geisinger E (2023) Genome-wide phage susceptibility analysis in <italic toggle="yes">Acinetobacter baumannii</italic> reveals capsule modulation strategies that determine phage infectivity. PLoS Pathog 19:e1010928. 10.1371/journal.ppat.1010928<pub-id pub-id-type="pmid">37289824</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.ppat.1010928</pub-id><pub-id pub-id-type="pmcid">PMC10249906</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR91"><label>91.</label><citation-alternatives><element-citation id="ec-CR91" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olszak</surname><given-names>T</given-names></name><name name-style="western"><surname>Shneider</surname><given-names>MM</given-names></name><name name-style="western"><surname>Latka</surname><given-names>A</given-names></name><name name-style="western"><surname>Maciejewska</surname><given-names>B</given-names></name><name name-style="western"><surname>Browning</surname><given-names>C</given-names></name><name name-style="western"><surname>Sycheva</surname><given-names>LV</given-names></name><etal/></person-group><article-title>The O-specific polysaccharide lyase from the phage LKA1 tailspike reduces Pseudomonas virulence</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1038/s41598-017-16411-4</pub-id><pub-id pub-id-type="pmid">29176754</pub-id><pub-id pub-id-type="pmcid">PMC5701251</pub-id></element-citation><mixed-citation id="mc-CR91" publication-type="journal">Olszak T, Shneider MM, Latka A, Maciejewska B, Browning C, Sycheva LV et al (2017) The O-specific polysaccharide lyase from the phage LKA1 tailspike reduces Pseudomonas virulence. Sci Rep 7:1&#8211;14. 10.1038/s41598-017-16411-4<pub-id pub-id-type="pmid">29176754</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-017-16411-4</pub-id><pub-id pub-id-type="pmcid">PMC5701251</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR92"><label>92.</label><citation-alternatives><element-citation id="ec-CR92" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barbirz</surname><given-names>S</given-names></name><name name-style="western"><surname>M&#252;ller</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Uetrecht</surname><given-names>C</given-names></name><name name-style="western"><surname>Clark</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Heinemann</surname><given-names>U</given-names></name><name name-style="western"><surname>Seckler</surname><given-names>R</given-names></name></person-group><article-title>Crystal structure of <italic toggle="yes">Escherichia coli</italic> phage HK620 tailspike: podoviral tailspike endoglycosidase modules are evolutionarily related</article-title><source>Mol Microbiol</source><year>2008</year><volume>69</volume><fpage>303</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1111/J.1365-2958.2008.06311.X</pub-id><pub-id pub-id-type="pmid">18547389</pub-id></element-citation><mixed-citation id="mc-CR92" publication-type="journal">Barbirz S, M&#252;ller JJ, Uetrecht C, Clark AJ, Heinemann U, Seckler R (2008) Crystal structure of <italic toggle="yes">Escherichia coli</italic> phage HK620 tailspike: podoviral tailspike endoglycosidase modules are evolutionarily related. Mol Microbiol 69:303&#8211;316. 10.1111/J.1365-2958.2008.06311.X<pub-id pub-id-type="pmid">18547389</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2958.2008.06311.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR93"><label>93.</label><citation-alternatives><element-citation id="ec-CR93" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sperandeo</surname><given-names>P</given-names></name><name name-style="western"><surname>Martorana</surname><given-names>AM</given-names></name><name name-style="western"><surname>Polissi</surname><given-names>A</given-names></name></person-group><article-title>The Lpt ABC transporter for lipopolysaccharide export to the cell surface</article-title><source>Res Microbiol</source><year>2019</year><volume>170</volume><fpage>366</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1016/j.resmic.2019.07.005</pub-id><pub-id pub-id-type="pmid">31376484</pub-id></element-citation><mixed-citation id="mc-CR93" publication-type="journal">Sperandeo P, Martorana AM, Polissi A (2019) The Lpt ABC transporter for lipopolysaccharide export to the cell surface. Res Microbiol 170:366&#8211;373. 10.1016/j.resmic.2019.07.005<pub-id pub-id-type="pmid">31376484</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.resmic.2019.07.005</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR94"><label>94.</label><citation-alternatives><element-citation id="ec-CR94" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sperandeo</surname><given-names>P</given-names></name><name name-style="western"><surname>Martorana</surname><given-names>AM</given-names></name><name name-style="western"><surname>Polissi</surname><given-names>A</given-names></name></person-group><article-title>The lipopolysaccharide transport (Lpt) machinery: a nonconventional transporter for lipopolysaccharide assembly at the outer membrane of Gram-negative bacteria</article-title><source>J Biol Chem</source><year>2017</year><volume>292</volume><fpage>17981</fpage><lpage>17990</lpage><pub-id pub-id-type="doi">10.1074/jbc.R117.802512</pub-id><pub-id pub-id-type="pmid">28878019</pub-id><pub-id pub-id-type="pmcid">PMC5672026</pub-id></element-citation><mixed-citation id="mc-CR94" publication-type="journal">Sperandeo P, Martorana AM, Polissi A (2017) The lipopolysaccharide transport (Lpt) machinery: a nonconventional transporter for lipopolysaccharide assembly at the outer membrane of Gram-negative bacteria. J Biol Chem 292:17981&#8211;17990. 10.1074/jbc.R117.802512<pub-id pub-id-type="pmid">28878019</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.R117.802512</pub-id><pub-id pub-id-type="pmcid">PMC5672026</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR95"><label>95.</label><citation-alternatives><element-citation id="ec-CR95" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whiteway</surname><given-names>C</given-names></name><name name-style="western"><surname>Valcek</surname><given-names>A</given-names></name><name name-style="western"><surname>Philippe</surname><given-names>C</given-names></name><name name-style="western"><surname>Strazisar</surname><given-names>M</given-names></name><name name-style="western"><surname>De Pooter</surname><given-names>T</given-names></name><name name-style="western"><surname>Mateus</surname><given-names>I</given-names></name><etal/></person-group><article-title>Scarless excision of an insertion sequence restores capsule production and virulence in <italic toggle="yes">Acinetobacter baumannii</italic></article-title><source>ISME J</source><year>2022</year><volume>16</volume><issue>5</issue><fpage>1473</fpage><lpage>1477</lpage><pub-id pub-id-type="doi">10.1038/s41396-021-01179-3</pub-id><pub-id pub-id-type="pmid">34949784</pub-id><pub-id pub-id-type="pmcid">PMC9038732</pub-id></element-citation><mixed-citation id="mc-CR95" publication-type="journal">Whiteway C, Valcek A, Philippe C, Strazisar M, De Pooter T, Mateus I et al (2022) Scarless excision of an insertion sequence restores capsule production and virulence in <italic toggle="yes">Acinetobacter baumannii</italic>. ISME J 16(5):1473&#8211;1477. 10.1038/s41396-021-01179-3<pub-id pub-id-type="pmid">34949784</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41396-021-01179-3</pub-id><pub-id pub-id-type="pmcid">PMC9038732</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR96"><label>96.</label><citation-alternatives><element-citation id="ec-CR96" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tipton</surname><given-names>KA</given-names></name><name name-style="western"><surname>Dimitrova</surname><given-names>D</given-names></name><name name-style="western"><surname>Rather</surname><given-names>PN</given-names></name></person-group><article-title>Phase-variable control of multiple phenotypes in <italic toggle="yes">Acinetobacter baumannii</italic> strain AB5075</article-title><source>J Bacteriol</source><year>2015</year><volume>197</volume><fpage>2593</fpage><lpage>2599</lpage><pub-id pub-id-type="doi">10.1128/JB.00188-15</pub-id><pub-id pub-id-type="pmid">26013481</pub-id><pub-id pub-id-type="pmcid">PMC4518826</pub-id></element-citation><mixed-citation id="mc-CR96" publication-type="journal">Tipton KA, Dimitrova D, Rather PN (2015) Phase-variable control of multiple phenotypes in <italic toggle="yes">Acinetobacter baumannii</italic> strain AB5075. J Bacteriol 197:2593&#8211;2599. 10.1128/JB.00188-15<pub-id pub-id-type="pmid">26013481</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JB.00188-15</pub-id><pub-id pub-id-type="pmcid">PMC4518826</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR97"><label>97.</label><citation-alternatives><element-citation id="ec-CR97" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmad</surname><given-names>I</given-names></name><name name-style="western"><surname>Karah</surname><given-names>N</given-names></name><name name-style="western"><surname>Nadeem</surname><given-names>A</given-names></name><name name-style="western"><surname>Wai</surname><given-names>SN</given-names></name><name name-style="western"><surname>Uhlin</surname><given-names>BE</given-names></name></person-group><article-title>Analysis of colony phase variation switch in <italic toggle="yes">Acinetobacter baumannii</italic> clinical isolates</article-title><source>PLoS ONE</source><year>2019</year><volume>14</volume><fpage>e0210082</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0210082</pub-id><pub-id pub-id-type="pmid">30608966</pub-id><pub-id pub-id-type="pmcid">PMC6319719</pub-id></element-citation><mixed-citation id="mc-CR97" publication-type="journal">Ahmad I, Karah N, Nadeem A, Wai SN, Uhlin BE (2019) Analysis of colony phase variation switch in <italic toggle="yes">Acinetobacter baumannii</italic> clinical isolates. PLoS ONE 14:e0210082. 10.1371/journal.pone.0210082<pub-id pub-id-type="pmid">30608966</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0210082</pub-id><pub-id pub-id-type="pmcid">PMC6319719</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR98"><label>98.</label><citation-alternatives><element-citation id="ec-CR98" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tierney</surname><given-names>ARP</given-names></name><name name-style="western"><surname>Chin</surname><given-names>CY</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>DS</given-names></name><name name-style="western"><surname>Rather</surname><given-names>PN</given-names></name></person-group><article-title>A lysR-type transcriptional regulator controls multiple phenotypes in <italic toggle="yes">Acinetobacter baumannii</italic></article-title><source>Front Cell Infect Microbiol</source><year>2021</year><pub-id pub-id-type="doi">10.3389/fcimb.2021.778331</pub-id><pub-id pub-id-type="pmid">34805000</pub-id><pub-id pub-id-type="pmcid">PMC8601201</pub-id></element-citation><mixed-citation id="mc-CR98" publication-type="journal">Tierney ARP, Chin CY, Weiss DS, Rather PN (2021) A lysR-type transcriptional regulator controls multiple phenotypes in <italic toggle="yes">Acinetobacter baumannii</italic>. Front Cell Infect Microbiol. 10.3389/fcimb.2021.778331<pub-id pub-id-type="pmid">34805000</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcimb.2021.778331</pub-id><pub-id pub-id-type="pmcid">PMC8601201</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR99"><label>99.</label><citation-alternatives><element-citation id="ec-CR99" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chin</surname><given-names>CY</given-names></name><name name-style="western"><surname>Tipton</surname><given-names>KA</given-names></name><name name-style="western"><surname>Farokhyfar</surname><given-names>M</given-names></name><name name-style="western"><surname>Burd</surname><given-names>EM</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>DS</given-names></name><name name-style="western"><surname>Rather</surname><given-names>PN</given-names></name></person-group><article-title>A high-frequency phenotypic switch links bacterial virulence and environmental survival in <italic toggle="yes">Acinetobacter baumannii</italic></article-title><source>Nat Microbiol</source><year>2018</year><volume>3</volume><fpage>563</fpage><lpage>569</lpage><pub-id pub-id-type="doi">10.1038/s41564-018-0151-5</pub-id><pub-id pub-id-type="pmid">29693659</pub-id><pub-id pub-id-type="pmcid">PMC5921939</pub-id></element-citation><mixed-citation id="mc-CR99" publication-type="journal">Chin CY, Tipton KA, Farokhyfar M, Burd EM, Weiss DS, Rather PN (2018) A high-frequency phenotypic switch links bacterial virulence and environmental survival in <italic toggle="yes">Acinetobacter baumannii</italic>. Nat Microbiol 3:563&#8211;569. 10.1038/s41564-018-0151-5<pub-id pub-id-type="pmid">29693659</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41564-018-0151-5</pub-id><pub-id pub-id-type="pmcid">PMC5921939</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR100"><label>100.</label><citation-alternatives><element-citation id="ec-CR100" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schooley</surname><given-names>RT</given-names></name><name name-style="western"><surname>Biswas</surname><given-names>B</given-names></name><name name-style="western"><surname>Gill</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Hernandez-Morales</surname><given-names>A</given-names></name><name name-style="western"><surname>Lancaster</surname><given-names>J</given-names></name><name name-style="western"><surname>Lessor</surname><given-names>L</given-names></name><etal/></person-group><article-title>Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant <italic toggle="yes">Acinetobacter baumannii</italic> infection</article-title><source>Antimicrob Agents Chemother</source><year>2017</year><pub-id pub-id-type="doi">10.1128/AAC.00954-17</pub-id><pub-id pub-id-type="pmid">28807909</pub-id><pub-id pub-id-type="pmcid">PMC5610518</pub-id></element-citation><mixed-citation id="mc-CR100" publication-type="journal">Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L et al (2017) Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant <italic toggle="yes">Acinetobacter baumannii</italic> infection. Antimicrob Agents Chemother. 10.1128/AAC.00954-17<pub-id pub-id-type="pmid">28807909</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AAC.00954-17</pub-id><pub-id pub-id-type="pmcid">PMC5610518</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR101"><label>101.</label><citation-alternatives><element-citation id="ec-CR101" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>N</given-names></name><name name-style="western"><surname>Dai</surname><given-names>J</given-names></name><name name-style="western"><surname>Guo</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>F</given-names></name><etal/></person-group><article-title>Pre-optimized phage therapy on secondary <italic toggle="yes">Acinetobacter baumannii</italic> infection in four critical COVID-19 patients</article-title><source>Emerg Microbes Infect</source><year>2021</year><volume>10</volume><fpage>612</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.1080/22221751.2021.1902754</pub-id><pub-id pub-id-type="pmid">33703996</pub-id><pub-id pub-id-type="pmcid">PMC8032346</pub-id></element-citation><mixed-citation id="mc-CR101" publication-type="journal">Wu N, Dai J, Guo M, Li J, Zhou X, Li F et al (2021) Pre-optimized phage therapy on secondary <italic toggle="yes">Acinetobacter baumannii</italic> infection in four critical COVID-19 patients. Emerg Microbes Infect 10:612&#8211;618. 10.1080/22221751.2021.1902754<pub-id pub-id-type="pmid">33703996</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/22221751.2021.1902754</pub-id><pub-id pub-id-type="pmcid">PMC8032346</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR102"><label>102.</label><citation-alternatives><element-citation id="ec-CR102" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rao</surname><given-names>S</given-names></name><name name-style="western"><surname>Betancourt-Garcia</surname><given-names>M</given-names></name><name name-style="western"><surname>Kare-Opaneye</surname><given-names>YO</given-names></name><name name-style="western"><surname>Swierczewski</surname><given-names>BE</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>JW</given-names></name><name name-style="western"><surname>Horne</surname><given-names>B</given-names></name><etal/></person-group><article-title>Critically ill patient with multidrug-resistant <italic toggle="yes">Acinetobacter baumannii</italic> respiratory infection successfully treated with intravenous and nebulized bacteriophage therapy</article-title><source>Antimicrob Agents Chemother</source><year>2022</year><pub-id pub-id-type="doi">10.1128/AAC.00824-21</pub-id><pub-id pub-id-type="pmid">34662188</pub-id><pub-id pub-id-type="pmcid">PMC8765271</pub-id></element-citation><mixed-citation id="mc-CR102" publication-type="journal">Rao S, Betancourt-Garcia M, Kare-Opaneye YO, Swierczewski BE, Bennett JW, Horne B et al (2022) Critically ill patient with multidrug-resistant <italic toggle="yes">Acinetobacter baumannii</italic> respiratory infection successfully treated with intravenous and nebulized bacteriophage therapy. Antimicrob Agents Chemother. 10.1128/AAC.00824-21<pub-id pub-id-type="pmid">34662188</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AAC.00824-21</pub-id><pub-id pub-id-type="pmcid">PMC8765271</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR103"><label>103.</label><citation-alternatives><element-citation id="ec-CR103" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nir-Paz</surname><given-names>R</given-names></name><name name-style="western"><surname>Gelman</surname><given-names>D</given-names></name><name name-style="western"><surname>Khouri</surname><given-names>A</given-names></name><name name-style="western"><surname>Sisson</surname><given-names>BM</given-names></name><name name-style="western"><surname>Fackler</surname><given-names>J</given-names></name><name name-style="western"><surname>Alkalay-Oren</surname><given-names>S</given-names></name><etal/></person-group><article-title>Successful treatment of <italic toggle="yes">antibiotic-resistant</italic>, poly-microbial bone infection with bacteriophages and antibiotics combination</article-title><source>Clin Infect Dis</source><year>2019</year><volume>69</volume><fpage>2015</fpage><lpage>2018</lpage><pub-id pub-id-type="doi">10.1093/cid/ciz222</pub-id><pub-id pub-id-type="pmid">30869755</pub-id></element-citation><mixed-citation id="mc-CR103" publication-type="journal">Nir-Paz R, Gelman D, Khouri A, Sisson BM, Fackler J, Alkalay-Oren S et al (2019) Successful treatment of <italic toggle="yes">antibiotic-resistant</italic>, poly-microbial bone infection with bacteriophages and antibiotics combination. Clin Infect Dis 69:2015&#8211;2018. 10.1093/cid/ciz222<pub-id pub-id-type="pmid">30869755</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/ciz222</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR104"><label>104.</label><citation-alternatives><element-citation id="ec-CR104" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LaVergne</surname><given-names>S</given-names></name><name name-style="western"><surname>Hamilton</surname><given-names>T</given-names></name><name name-style="western"><surname>Biswas</surname><given-names>B</given-names></name><name name-style="western"><surname>Kumaraswamy</surname><given-names>M</given-names></name><name name-style="western"><surname>Schooley</surname><given-names>RT</given-names></name><name name-style="western"><surname>Wooten</surname><given-names>D</given-names></name></person-group><article-title>Phage therapy for a multidrug-resistant <italic toggle="yes">Acinetobacter baumannii</italic> craniectomy site infection</article-title><source>Open Forum Infect Dis</source><year>2018</year><pub-id pub-id-type="doi">10.1093/ofid/ofy064</pub-id><pub-id pub-id-type="pmid">29687015</pub-id><pub-id pub-id-type="pmcid">PMC5905571</pub-id></element-citation><mixed-citation id="mc-CR104" publication-type="journal">LaVergne S, Hamilton T, Biswas B, Kumaraswamy M, Schooley RT, Wooten D (2018) Phage therapy for a multidrug-resistant <italic toggle="yes">Acinetobacter baumannii</italic> craniectomy site infection. Open Forum Infect Dis. 10.1093/ofid/ofy064<pub-id pub-id-type="pmid">29687015</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ofid/ofy064</pub-id><pub-id pub-id-type="pmcid">PMC5905571</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR105"><label>105.</label><citation-alternatives><element-citation id="ec-CR105" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Russo</surname><given-names>TA</given-names></name><name name-style="western"><surname>Beanan</surname><given-names>JM</given-names></name><name name-style="western"><surname>Olson</surname><given-names>R</given-names></name><name name-style="western"><surname>MacDonald</surname><given-names>U</given-names></name><name name-style="western"><surname>Cox</surname><given-names>AD</given-names></name><name name-style="western"><surname>St. Michael</surname><given-names>F</given-names></name><etal/></person-group><article-title>The K1 capsular polysaccharide from <italic toggle="yes">Acinetobacter</italic>
<italic toggle="yes">baumannii</italic> is a potential therapeutic target via passive immunization</article-title><source>Infect Immun</source><year>2013</year><volume>81</volume><fpage>915</fpage><lpage>922</lpage><pub-id pub-id-type="doi">10.1128/IAI.01184-12</pub-id><pub-id pub-id-type="pmid">23297385</pub-id><pub-id pub-id-type="pmcid">PMC3584894</pub-id></element-citation><mixed-citation id="mc-CR105" publication-type="journal">Russo TA, Beanan JM, Olson R, MacDonald U, Cox AD, St. Michael F et al (2013) The K1 capsular polysaccharide from <italic toggle="yes">Acinetobacter</italic><italic toggle="yes">baumannii</italic> is a potential therapeutic target via passive immunization. Infect Immun 81:915&#8211;922. 10.1128/IAI.01184-12<pub-id pub-id-type="pmid">23297385</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.01184-12</pub-id><pub-id pub-id-type="pmcid">PMC3584894</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR106"><label>106.</label><citation-alternatives><element-citation id="ec-CR106" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nielsen</surname><given-names>TB</given-names></name><name name-style="western"><surname>Yan</surname><given-names>J</given-names></name><name name-style="western"><surname>Slarve</surname><given-names>M</given-names></name><name name-style="western"><surname>Lu</surname><given-names>P</given-names></name><name name-style="western"><surname>Li</surname><given-names>R</given-names></name><name name-style="western"><surname>Ruiz</surname><given-names>J</given-names></name><etal/></person-group><article-title>Monoclonal antibody therapy against <italic toggle="yes">Acinetobacter</italic>
<italic toggle="yes">baumannii</italic></article-title><source>Infect Immun</source><year>2021</year><pub-id pub-id-type="doi">10.1128/iai.00162-21</pub-id><pub-id pub-id-type="pmid">34310884</pub-id><pub-id pub-id-type="pmcid">PMC8445169</pub-id></element-citation><mixed-citation id="mc-CR106" publication-type="journal">Nielsen TB, Yan J, Slarve M, Lu P, Li R, Ruiz J et al (2021) Monoclonal antibody therapy against <italic toggle="yes">Acinetobacter</italic><italic toggle="yes">baumannii</italic>. Infect Immun. 10.1128/iai.00162-21<pub-id pub-id-type="pmid">34310884</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.00162-21</pub-id><pub-id pub-id-type="pmcid">PMC8445169</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR107"><label>107.</label><citation-alternatives><element-citation id="ec-CR107" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nielsen</surname><given-names>TB</given-names></name><name name-style="western"><surname>Yan</surname><given-names>J</given-names></name><name name-style="western"><surname>Slarve</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>R</given-names></name><name name-style="western"><surname>Junge</surname><given-names>JA</given-names></name><name name-style="western"><surname>Luna</surname><given-names>BM</given-names></name><etal/></person-group><article-title>Development of a bispecific antibody targeting clinical isolates of <italic toggle="yes">Acinetobacter baumannii</italic></article-title><source>J Infect Dis</source><year>2023</year><volume>227</volume><fpage>1042</fpage><lpage>1049</lpage><pub-id pub-id-type="doi">10.1093/INFDIS/JIAC499</pub-id><pub-id pub-id-type="pmid">36617220</pub-id><pub-id pub-id-type="pmcid">PMC10319980</pub-id></element-citation><mixed-citation id="mc-CR107" publication-type="journal">Nielsen TB, Yan J, Slarve M, Li R, Junge JA, Luna BM et al (2023) Development of a bispecific antibody targeting clinical isolates of <italic toggle="yes">Acinetobacter baumannii</italic>. J Infect Dis 227:1042&#8211;1049. 10.1093/INFDIS/JIAC499<pub-id pub-id-type="pmid">36617220</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/jiac499</pub-id><pub-id pub-id-type="pmcid">PMC10319980</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR108"><label>108.</label><citation-alternatives><element-citation id="ec-CR108" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>JK</given-names></name><name name-style="western"><surname>Adams</surname><given-names>FG</given-names></name><name name-style="western"><surname>Brown</surname><given-names>MH</given-names></name></person-group><article-title>Diversity and function of capsular polysaccharide in <italic toggle="yes">Acinetobacter baumannii</italic></article-title><source>Front Microbiol</source><year>2019</year><pub-id pub-id-type="doi">10.3389/fmicb.2018.03301</pub-id><pub-id pub-id-type="pmid">30687280</pub-id><pub-id pub-id-type="pmcid">PMC6333632</pub-id></element-citation><mixed-citation id="mc-CR108" publication-type="journal">Singh JK, Adams FG, Brown MH (2019) Diversity and function of capsular polysaccharide in <italic toggle="yes">Acinetobacter baumannii</italic>. Front Microbiol. 10.3389/fmicb.2018.03301<pub-id pub-id-type="pmid">30687280</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmicb.2018.03301</pub-id><pub-id pub-id-type="pmcid">PMC6333632</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR109"><label>109.</label><citation-alternatives><element-citation id="ec-CR109" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang-Lin</surname><given-names>SX</given-names></name><name name-style="western"><surname>Olson</surname><given-names>R</given-names></name><name name-style="western"><surname>Beanan</surname><given-names>JM</given-names></name><name name-style="western"><surname>MacDonald</surname><given-names>U</given-names></name><name name-style="western"><surname>Balthasar</surname><given-names>JP</given-names></name><name name-style="western"><surname>Russo</surname><given-names>TA</given-names></name></person-group><article-title>The capsular polysaccharide of <italic toggle="yes">Acinetobacter</italic>
<italic toggle="yes">baumannii</italic> is an obstacle for therapeutic passive immunization strategies</article-title><source>Infect Immun</source><year>2017</year><volume>85</volume><fpage>10</fpage><lpage>1128</lpage><pub-id pub-id-type="doi">10.1128/iai.00591-17</pub-id><pub-id pub-id-type="pmcid">PMC5695103</pub-id><pub-id pub-id-type="pmid">28947651</pub-id></element-citation><mixed-citation id="mc-CR109" publication-type="journal">Wang-Lin SX, Olson R, Beanan JM, MacDonald U, Balthasar JP, Russo TA (2017) The capsular polysaccharide of <italic toggle="yes">Acinetobacter</italic><italic toggle="yes">baumannii</italic> is an obstacle for therapeutic passive immunization strategies. Infect Immun 85:10&#8211;1128. 10.1128/iai.00591-17<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/IAI.00591-17</pub-id><pub-id pub-id-type="pmcid">PMC5695103</pub-id><pub-id pub-id-type="pmid">28947651</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR110"><label>110.</label><citation-alternatives><element-citation id="ec-CR110" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>G</given-names></name><name name-style="western"><surname>Lin</surname><given-names>L</given-names></name><name name-style="western"><surname>Ibrahim</surname><given-names>AS</given-names></name><name name-style="western"><surname>Baquir</surname><given-names>B</given-names></name><name name-style="western"><surname>Pantapalangkoor</surname><given-names>P</given-names></name><name name-style="western"><surname>Bonomo</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Active and passive immunization protects against lethal, extreme drug resistant-<italic toggle="yes">Acinetobacter baumannii</italic> infection</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><fpage>e29446</fpage><pub-id pub-id-type="doi">10.1371/JOURNAL.PONE.0029446</pub-id><pub-id pub-id-type="pmid">22253723</pub-id><pub-id pub-id-type="pmcid">PMC3254619</pub-id></element-citation><mixed-citation id="mc-CR110" publication-type="journal">Luo G, Lin L, Ibrahim AS, Baquir B, Pantapalangkoor P, Bonomo RA et al (2012) Active and passive immunization protects against lethal, extreme drug resistant-<italic toggle="yes">Acinetobacter baumannii</italic> infection. PLoS ONE 7:e29446. 10.1371/JOURNAL.PONE.0029446<pub-id pub-id-type="pmid">22253723</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0029446</pub-id><pub-id pub-id-type="pmcid">PMC3254619</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>